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Ledebouria zebrina and Scilla natalensis Planch were the two species investigated in
this work.
Ledebouria zebrina belongs to the Hyacinthaceae (Liliacea sensu lato) and to this
date, the chemical composition of this species has not been investigated. Members of
this family are found in southern Africa. The Ledebouria genus was formerly
classified as part of the Scilla genus from which a large member of naturally occuring
oxygen heterocycles known as homoisoflavanones have been isolated. In this work
the bulbs of L. zebrina were investigated and five compounds were isolated. Three
compounds were of the homoisoflavanone type while the remaining two belong to the
eucosterol type triterpernoids.
Scilla natalensis Planch also belongs to the Hyacinthaceae family. Previous chemical
investigations of the bulbs of this plant yield two homoisoflavanones of the 3-benzyl-
4-chromanone type. Members of this family are mostly found in the Eastern parts of
the country, ranging from the Eastern Cape to Mpumalanga province including
Lesotho and Swaziland. The bulbs of this plant were investigated and this yielded ten
compounds.
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Since ancient times people have used medicinal plants. In China, medicinal plants have
long enjoyed a prominent role in healthcare services. Chinese traditional medicine has a
history extending back 4000 years with the Yellow Emperor's Classic of Internal
Medicine considered to be the world's oldest extant medical book. l Medicinal plants in
India have been collected in the wild and cultivated for millennia. The Rig Veda, written
in India between the 4800-1600 BC is the earliest record in India of the use of trees,
shrubs, herbs and grass combinations for curing aliments.' The ancient kingdoms and
empires of Africa, such as Ethiopia, Nubia and Somalia had extensive codified healing
recipes.2 The history of healing arts in Africa can be traced back to ca. 3200 BC, when
the Ebers Papyrus, one of the oldest medical literatures, listed several recipes used by
ancient Egyptian healers.2
There is no clear distinction in traditional African medicine as to when a herb ceases to
be a health food and when it becomes a medicine. In traditional African medicine, many
food plants are used for therapeutic purposes, and medicines are not viewed as "necessary
poisons". This is in contrast to Western orthodox medicine in which many drugs are seen
as poisons, which in low doses may cure diseases. African plants such as the calabar bean
(Physostigma venenosum) (Figure 1.1), Strophanthus, Kola, the Madagascan periwinkle
(Catharanthus roseus) and the Devils Claw (Harpagophytum procumbens) all have made
it onto the pharmaceutical market. Something that is interesting to note is that there are
African varieties of several "official" drugs. The African Rauvolfia vomitoria, for
example, has a higher content of the antihypertensive alkaloid reserpine than the better-
known Indian species. One of the best known African medicinal plants is the calabar
bean. It contains alkaloids, which are used in the treatment of glaucoma and can prevent
blindness.
Physostigma v~ncnosumBall. f.
Figure 1.1: Illustration of Physostigma venenosum, Photo:Erik Gotfredsen, website:
hUp:llwww.liberherbarum.com/Pn0677ko.htm
Although there is a large number of research publications available on the constituents
and biological activity of medicinal plants from Africa, the development of therapeutic
agents from African medicinal plants has remained a somewhat neglected subject. The
study of African medicinal plants also has not been taken as seriously and documented as
fully as in other traditional societies, such as Indian and Chinese. Our knowledge of
African medicinal plants is accordingly relatively limited. The little information available
is often fragmented and incomplete following erosion of African healing cultures.
China has a rich heritage of medicinal plants. Traditional medicine is nowhere used more
extensively than in China. Medicinal plants are important to the Chinese economy and
they comprise a 40 percent share of the national medicine market. I The majority of
China's factory-processed drugs are of plant origin. In fact, medicinal plant preparations
are almost as important as synthetic drugs, such as antibiotics.
The most famous among Chinese traditional medicines is ginseng (Figure 1.2) from the
plant Panax ginseng. 4 The ancient Chinese used ginseng to balance the body's "positive
and negative energy" and, if it was taken regularly it was said to prolong life. Clinical
2




Figure 1.2: Panax ginseng from which ginseng is extracted, no photographer given, website:
http://guickchan2e.com/2insen2store/
In India the majority of the population has used ancient practices known as Ayurvedic
and Unain. However, the trained physicians mostly ignore these practises. This is truly
unfortunate for much more could be learned and understood if the physicians and ancient
practitioners worked together. An example is in the new evidence of lipid permeability of
skin which supplies a logical scientific basis for the use of the traditional Ayurvedic
techniques of oil and milk herbal massages and partial baths for headaches, rheumatism
and eye ailments.3
One of the most famous amongst the plants ofIndia is the neem tree (Azadirachta indica)
(Figure 1.3). For centuries people have cleaned their teeth with the neem twigs and
smeared skin disorders with neem-Ieaf juices. The tree has been used to relieve so many
different pains, fevers, infections and other complaints that it has been called the "village
pharmacy".5
3
Figure 1.3: Azadirachta indica used by Indians for centuries, no photographer given, website:
http://www.neemfoundation.org/intro.htm
Plants continue to be important sources for new drugs. The podophyllum resin of the
mayapple (Podophyllum peltatum) (Figure 1.4) has long been used as a purgative, but
the discovery of the cytotoxic properties of podophyllotoxin has subsequently led to the
development of a commercially important drug. Although podophyllotoxin was found to
be unsuitable as an anticancer agent because of its toxic side effects, its semi-synthetic
derivative etoposide, which is manufactured from the resin of podophyllum, has been
reported to be useful in the chemotherapeutic treatment of refractory testicular
carcmomas, non-lymphocytic leukemias and non-Hodgkin's lymphomas, usually in





Figure 1.4: Structure of etopside (right) a derivative of natural podophyUum resin which is extracted
from Podophyllum peltatum (left), Photo: Daniel Reed, website: www.2bnthewild.com
4
Figure 1.5: Structure of taxol (right) which is extracted from Taxus brevifolia (left), Photo: John
Worrall, website: http://www.science.ubc.ca/-frst1111Cl~i-bin/db t:allery/expand.ct:i?search=611
Taxol is another potent anticancer natural product. Taxol was isolated from the bark of
the pacific yew (Taxus brevifalia) (Figure 1.5). It is active against a number ofleukemias
and solid tumours of the breast, ovary and lungs in humans. The current problem with
taxol is the difficulty in obtaining the drug. The amount of taxol in the yew bark is low
and it takes 100 years to grow the tree, which only yields enough taxol to treat one
patient. Also although it has been produced by total synthesis this is not a commercially
viable method of producing it. Currently a semi-synthetic form of taxol is being
produced. Recently a semi-synthetic derivative (Taxotere®), which comes from the
needles of the yew tree (a renewable resource), has been approved by the Food and Drug
Administration (FDA) for the treatment of breast and lung cancer. Other plant-derived
compounds that have aided in the fight against cancer are compounds such as vincristine
and vinblastine of the Madagascan periwinkle. Vinblastine is used for the treatment of
Hodgkin's disease, breast cancer and testicular carcinoma.8 Vincristine also from the
same plant showed a different spectrum of activity and toxicity. 8 However, it was found
to be neurotoxic and is now used in combination with other drugs in cancer
chemotherapy.8
5
One of the worlds most used drugs is aspirin (Figure 1.6). It is a derivative of the
naturally-occurring salicin originally derived from willows (Salix spp.). It is used
universally as a pain reliever.
salicin aspmn
Figure 1.6: Structure of salicin and its acetylated form, aspirin
A new plant-derived drug is galanthamine (Figure 1.7) which was first isolated from
Galantus nivalis but has now been found in many Amaryllidaceae species. It has recently
been approved (February 2001) by the FDA for the treatment of Alzheimer's disease.
alanthamine
Figure 1.7: Structure of galanthamine (right) which was originally extracted from the bulbs of
Galantus nivalis, Photo: John Worrall, website: http://www.hort.net/eallery/view/amY/ealni40/
Plants have also played a major part ill the production of substances from which
contraceptives are manufactured. Plants such as soybeans, yams and sisal all have made a
great contribution towards stabilizing the world population. They provided the basic
6
compounds from which steroidal compounds, now cheaply available as oral
contraceptives, are synthesized. A good example is diosgenin (Figure 1.8), which is




Figure 1.8: Structure of diosgenin which is used in steroid hormonal synthesis
Most spices, teas and other beverages such as coffee and cocoa owe their individual
properties (flavours and aromas) to the pharmacologically active plant metabolites that
they contain.7 Most of them contain the purine alkaloids, caffeine, theobromine and
theophylline. These are found naturally in the leaves, seeds and fruits of more than sixty
plants. They may also be produced synthetically. Caffeine (Figure 1.9) is extracted
mainly from tea leaves, coffee beans and coca beans. Caffeine is used to stimulate the




Figure 1.9: Structure of caffeine (right) which is extracted mainly from Camellia sinensis (left)
photographer not given, website: http://www.plantoftheweek.or~/week046.shtml
One plant that had a mixed effect on mankind is Papaver somniferum (Figure 1.10), the
opium poppy. It is the oldest known intoxicating plant in human history.9 It was used in
India, Taiwan and China where the desire for tranquility and sweet dreams led to
numerous poisonings.9 More than twenty alkaloids have been extracted from the opium
poppy.9 The most important ones are morphine, which is an important analgesic, codeine,
which is a common ingredient of cough medicines and papaverine which is used in
relieving the pain of stomach-ache.9 Morphine and codeine were also the model from
which synthetic analgesic drugs such as meperidine (Demerol), pentazocine (Talwin) and
propoxyphene (Darvon) were synthesized.9 Morphine has played another big, yet evil,






Figure 1.10: Structure of various alkaloids (right) isolated and also derived from Papaver somniferum
(left), no photographer given, website: http://Iibrary.thinkguest.org/C007974/11pop.htm
Extracts of plants have been used as insecticides by humans since before the time of the
ancient Romans, a practice that continues to the present. There are over two thousand
species of plant known to have insecticidal properties.6 The use of insecticidal plants is
prevalent in the developing countries, where plants grown locally are cheaper for
subsistence farmers than are synthetic chemical pesticides. A commonly-used natural
pesticide is pyrethrin extracted from Chrysanthemum cinerariaefolium. Pyrethrins are





pyrethrin I Me CH=CH2
pyrethrin 11 C02Me CH=CH2
Figure 1.11: Structure of pyrethrins I and 11 which are used in insecticides
9
Plant natural products have long been, and will continue to be, important sources and
models for drugs, insecticides and spices. Natural products often serve as chemical
models for the design and synthesis of new drug entities. This is therefore a field of
research that encourages one to study traditional practices of indigenous populations
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Chapter 2: The Classification and Biosynthesis of
Homoisoflavanones and Triterpenoids
2.1 Introduction
The Family Hyacinthaceae, formerly part of the Liliaceae, sensu lato, is richly
represented in southern Africa. It comprises approximately sixty-seven genera and
nine hundred species worldwide of which twenty-seven genera and three hundred and
sixty-eight taxa are located in southern Africa.40,41 The other major region of
Hyacinthaceae diversity is from the Mediterranean to South West Asia.42
Within southern Africa, the Hyacinthaceae are widespread and well adapted to the
fluctuating moist-arid climate, often withering down to bulbs during seasonal dry
periods. In this study the phytochemistry of the bulbs of the plants were studied.
Although great difficulties in phylogenetically systematizing the genera have been
acknowledged, a recent arrangement has been proposed.40-42 Of the five sub-families
delimited by Speta, three occur in southern Africa. These are the Hyacinthoideae,
Urgineoideae and the Ornithogaloideae. In this study Ledebouria zebrina and Scilla
natalensis were studied. Both belong to the sub-family Hyacinthoideae.
The two major classes of compounds isolated during this work were
homoisoflavanones and eucosterol type nortriterpenoids. The biosynthesis of these
compounds will be discussed in this chapter.
12
2.2 The Classification of Homoisoflavanones
The numbering of the basic homoisoflavanone skeleton is similar to that of all simple
flavonoid compounds and is shown below (Figure 2.1) using a 3-benzyl-4-
chromanone type (1) and a scillascillin type (2) as examples.
o
(1) (2)
Figure 2.1: The numbering system for homoisoflavanones
Homoisoflavanones belong to a small family of natural products whose first member
was isolated from the bulbs of Eucomis bicolor Bak. 1 They are restricted in their
distribution, having been previously reported to occur mainly in taxa of the
Hyacinthaceae?-IO However, these homoisoflavanones have also been reported to
occur outside this family. Intricatin and intricatinol are two homoisoflavanones
isolated from the Fabaceae Family (Section 2.6). Within the Hyacinthaceae, members
of the genus Scilla, Eucomis and Muscari have been dominant with regard to the
production ofhomoisoflavanones.2-5
Homoisoflavanones, which are more commonly referred to as homoisoflavonoids,
belong to a class of naturally occurring oxygen heterocycles. 11 The term
homoisoflavonoid is actually a misnomer since these compounds don't undergo the
characteristic 2,3-aryl migration of the C6-C3-C-6 moiety that is common in the
biosynthesis of isoflavonoids. 10 Also, they have a sixteen-carbon skeleton instead of a
fifteen-carbon skeleton characteristic of isoflavonoids. 13 The correct systematic name
is 3-benzyl-4-chromanone. The spectroscopic behavior of the homoisoflavanones
resembles very closely that of flavonoids. 14 This sixteen carbon skeleton bears either a
13
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chromanone, chromone or chromane moiety to which is attached, in most cases, a
benzyl or benzylidene group at the 3-position.16 The homoisoflavanones can generally
be classified into three types based on structural features: 11,14,16
2.2.1 The 3-benzyl-4-chromanone or dihydroeucomin type
Figure 2.2: A homoisoflavanone of the 3-benzyl-4-chromanone type
This type of homoisoflavanone (Figure 2.2) shows a very characteristic coupling
pattern in the 1H NMR spectrum due to the 2H-2, H-3, 2H-9 proton coupled system.
A pair of double doublets within the chemical shift range 8 4.10-4.32 ppm [AB of
ABX, 2H-2], one multiplet in the range 8 2.72-2.87 ppm [H-3] and two double
doublets in the range 8 2.65-2.73 ppm and 8 3.10-3.26 ppm [2H-9] are indicative of
this arrangement.






Figure 2.3: A homoisoflavanone of the 3-benzyl-3-hydroxy-4-chromanone type
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These compounds (Figure 2.3) typically possess a hydroxy substituent at C-3. The
characteristic feature in the IH NMR spectrum of this type ofhomoisoflavanone is the
presence of two AB systems, one for the C-2 protons at D4.20-4.36 ppm and D4.12-
4.17 ppm and another at D3.10-3.20 ppm and D2.65-2.75 ppm for the protons at C-
9. 13




Figure 2.4: A homoisoflavanone of the 3-benzylidene-4-chromanone type
These compounds (Figure 2.4) are characterized by a 3,9-double bond and can be in
the (Z)- or the (E)-configuration. The characteristic features in the IH NMR spectrum
are the presence of an AB-system for 2H-2 and a singlet for H-9. The pair of doublets
of 2H-2 are found to resonate at approximately D5.2-5.5 ppm while the resonance of
H-9 depends on the configuration. The (Z)-configuration places the proton at C-9
away from the anisotropic region of the carbonyl group and causes the vinyl group
proton to resonate at approximately D5.5 ppm. In the (E)-configuration the proton at
C-9 proton is in the anisotropic region of the carbonyl group and causes it to resonate
at D7.6-7.9 ppm. 13
Besides these three basic structural types, a number of unusual compounds which
contain a fourth ring (Figure 2.5), have been isolated. ll ,16 These compounds are
thought to be biogenetically related to homoisoflavanones and are classified with this
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groUp.10,II,14 Scillascillin type compounds possess a unique 3-spiro-cyclobutane ring
sytem. 14,16 The C-4 carbonyl group is retained in scillascillin-type compounds but is
absent in brazilin and hematoxylin where a cyclopentane C-ring is observed. The
biosynthetic origin of these more complex compounds has been investigated and it






Figure 2.5: Homoisoflavanones of the scillascillin, brazilin and hematoxylin types
The IH NMR spectrum of homoisoflavanones shows also a number of characteristic
features besides the splitting pattern of the H-2, H-9 and H-3 protons which are
important in the structural elucidation of these compounds. The signals between 8
6.50-7.20-ppm generally indicate the substitution pattern on the B-ring. This is either
an ABX or an AA'BB' system. The substituents present are attached to C-4' (AA'BB'
system) or C-3' and C-4' (ABX system). The proton resonances ofC-I', C-5' and C-6'
all appear as double doublets. In most cases the para coupling is not seen.
The region between 8 5.80-6.30 ppm indicates the substituent pattern on the A-ring.
There is usually only one or two proton resonances in this region which are normally
due to H-6 and/or H-8. The position of the proton is normally assigned through the
NOESY spectrum which shows NOESY correlations with the substituents at C-5 and
C-7.
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The mass spectrum is another important tool used in the determination of the structure
of the compound. The first step is cleavage of the C-3, C-9 bond in what is known as
an A-4 type cleavage. In dihydroeucomin this leads to fragments at m/z 180 and m/z
121 as shown in scheme 2.1. In most cases the tropylium ion gives rise to the base
peak of the spectrum. One of the fragments formed may then undergo a retro-Diels
Alder (RDA) reaction. In dihydroeucomin the chromanone fragment ion at m/z 180
may eliminate water, CO or undergo a RDA cleavage to give a fragment ion at m/z
152 or due to a hydrogen shift, m/z 153. The major pathway is the RDA cleavage and
H-shift. The minor pathway is usually the subsequent loss of water, CO and methyl
















Scheme 2.1: Fragmentation pattern of homoisoflavanones
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2.3 The Biosynthesis of Homoisoflavanones
Phenolic compounds can be biosynthesized via the shikimate pathway or polyketide
pathway.17 Often compounds like flavonoids and homoisoflavanones are of mixed
biosynthetic origin. In homoisoflavanones, the A-ring is polyketide derived while the














Figure 2.6: The origin of the A and Brings
The first step in the biosynthetic pathway leading to homoisoflavanones involves the
formation of a chalcone. Since chalcones are known to be direct precursors of
homoisoflavanones, the biosynthesis of chalcones is essentially a part of the
biogenetic route to homoisoflavanones. IO,13,14 The precursors to chalcones are three
malonyl CoA units and p-coumaroyl CoA.23-25
Malonyl-CoA is synthesized from acetyl-CoA and CO2.
23
-
25 The reaction, which is
shown below is catalysed by Acetyl-CoA carboxylase in the presence of adenosine 5'-
triphosphate (ATP) and Mg2+.23-25
p-Coumaroyl CoA, the second precursor in chalcone formation, is derived from the
shikimate pathway. This pathway is responsible for the production of the hydroxy
cinnamic ester, from which the B-ring is derived.23-25 The precursors of the shikimic
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acid pathway, erythrose-4-phosphate and phosphoenolpyruvate, are pnmary
metabolites of carbohydrate metabolism.23-25
The first step in the formation of the precursor is the deamination of phenylalanine,
which is catalyzed by the enzyme phenylalanine ammonia lyase (PAL).23-25 PAL
catalyses the anti-elimination of ammonia and the (pro-3s)-proton from L-phenyl-
alanine to yields trans-cinnamic acid.23-25 Cinnamate-4-hydroxylase (C4H) catalyses
the introduction of a hydroxy group into position 4 of the trans-cinnamic acid.23-25
This reaction requires NADPH and molecular oxygen and exhibits properties
characteristic for plant P450 enzymes.23-25 This reaction mechanism involves a H-
shift. The proton in the 4-position is oxidised to a hydroxy group, being moved itself
to the 3-position. This shift was established by trituim-Iabelling experiments
performed at the National Institute of Health at Bethesda, Washington D.e. and is






Figure 2.7: The NIH shift for the hydroxylation of cinnamic acid23-25
The p-coumaric acid is activated by the formation of a CoA ester, which is catalysed
by 4-coumarate: CoA ligase.23-25 This reaction which requires ATP and Mg2+ as






























.pAL= phenylalanine ammonia-lyase, C4H= cinnarnate-4-hydroxylase
Scheme 2.2: The biosynthesis of the intermediate p-coumaroyl CoA23-25
The formation of the chalcone is common to all classes of flavonoids and is thought to
be the most important step in flavonoid biosynthesis.23-25 The formation of the
chalcone is catalysed by the enzyme chalcone synthase,z4,25 Since chalcone is the
central intermediate for all flavonoids, chalcone synthase can be regarded as the key
enzyme in flavonoid biosynthesis.23-25 The overall reaction consists of three
successive condensation steps with "acetate units" being derived from malonyl-
COA.23-25 The result is the elongation of the aliphatic side chain of 4-coumarate by six
carbon atoms (Scheme 2.3).23 The enzyme chalcone synthase then catalyzes the
cyclization to give the aromatic ring A.23
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Scheme 2.3: The biosynthesis of the 2',4',6',4-tetrahydroxychalcone23.25
In many biosynthetic pathways, S-substituted methionine is often the source of an
additional carbon atom. Tetrahydroxychalcone IS methylated with S-
adenosylmethionine and is converted to the 2'-methoxy-4',6',4-trihydroxychalcone.








OH 0 OH 0
2',4',6',4-tetrahydroxychalcone 2'-trethoxy-4',6',4-trihydroxychalcone
Figure 2.8: The formation of the 2'-methoxy-4',6',4-trihydroxychalcone23-25
A scheme for the conversion of chalcones to homoisoflavanones has been proposed
by Dewick9 whereby the 2'-methoxy group is oxidised and then undergoes a
subsequent cyclisation which produces the three basic types of homoisoflavanones.
The addition of a hydride ion produces the 3-benzyl-4-chromanone type while the loss
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of a proton leads to the formation of the 3-benzylidene-4-chromanones.9 Hydration or
oxidation at the C-3 position of a 3-benzyl-4-chromanone leads to a 3-benzyl-3-























OH 0 OH 0
3-benzy~3-hydroxy~hroD1anone 3-benzyl~hroD1anone
Scheme 2.4: The proposed biosynthetic routes to basic homoisoflavanones9
Scillascillin type compounds which have a 3-spirocyclobutenyl ring are derived from
a more complex mechanism. The precursor to scillascillin-type homoisoflavanones is




Scheme 2.5: The proposed biosynthetic route to scillascillin type homoisoflavanones9
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2.4 The Triterpenoids of the Hyacinthaceae
The diverse, widespread and large family of natural products constructed from five
carbon units (isoprene units) and comprising compounds with a Cs, CIO, C IS, C20, C 2S,
C30 or C40 skeleton are termed terpenoids.
17 These compounds are found in all parts of
higher plants and also occur in mosses, liverworts, algae and lichens. The term
"triterpenoid" refers to C30 compounds that are derived from squalene.
18 They have
been known and investigated for over 100 years.
Spirocyclic nortriterpenoids have been isolated from members of the Hyacinthaceae.
These compounds have a basic lanosterol triterpenoid skeleton. Eucosterol and 16~­
hydroxyeucosterol are the two main types of nortriterpenoids isolated from various
Hyacinthaceae species. 19 The phytochemical investigation of Veltheimia braeteata
and Eueomis bieolor has also produced a number of lanosterol oligosaccharides that
are closely related to eucostero1.20,21 The variation in these compounds is due to the
differing degrees of oxygenation in the aglycone and the different combination of
sugars present.
The basic sterol numbering according to the IUPAC-IUB Rules for Sterol
Nomenclature of 1967 is given in Figure 2.9a. However in 1989 there was a major
change in the carbon numbering system (Figure 2.9b). In this work the numbering
system of IUPAC-IUB (1989) will be used although most of the literature on these






Figure 2.9: Basic structure of a sterol with carbon numbering. (a) Numbering according to the
IUPAC-IUB (1976) recommendations. (b) Numbering according to the IUPAC-IUB (1989)
recommendations




Figure 2.10: The structure of eucosterol
The majority of triterpenoids isolated in this work were found to be derivatives of
eucosterol (Figure 2.10). The key features in the IH and l3C NMR spectra of
eucosterol type compounds will be discussed here and will serve as the standard from
which all the structures of the derivatives of eucosterol were determined in this work.
The ranges of the NMR resonances for these types of compounds are given below.
The exact values for eucosterol are given in brackets.
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The IH NMR spectrum of eucosterol-type compounds shows a pair of doublets at 8
3.30-3.50 (3.38 in eucosterol) and 4.0-4.20 ppm (4.23 ppm) for the methylene protons
of the CH20H group (C-29) and a multiplet for the proton at C-3 at 8 3.40-3.60 ppm
(3.47 ppm). The methine proton at C-23 occurs as a triplet at approximately 8 4.64-
4.80 ppm (4.67 ppm).
There are six methyl groups in the molecule. The 3H-26 methyl group protons
resonate as a triplet at approximately 8 1.05-1.12 ppm (1.09 ppm). The 3H-21 methyl
group protons resonate as a doublet at approximately 8 1.10-1.20 ppm (1.15 ppm).
The 3H-18 and 3H-19 methyl group proton singlets resonate at approximately 8 0.9-
1.05 ppm (0.96 and 0.98 ppm respectively), while the methyl proton singlet
resonances of 3H-28 and 3H-30 resonate at approximately 8 1.05-1.30 (1.28 ppm) and
1.27-1.41 ppm (1.41 ppm) respectively. The 13C NMR spectrum shows two carbonyl
resonances at approximately 8 215 and 211 ppm for C-15 and C-24 respectively
(215.1 ppm and 211.7 ppm in eucosterol). The fully substituted C-O resonance of C-
17 occurs relatively downfield at approximately 8 91-100 ppm (99.2 ppm). The
presence of an ether linkage in eucosterol is shown by the presence of six carbons
bonded to oxygen atoms in the I3C NMR spectrum whilst the molecular formula has
only five oxygen atoms. This ether linkage is placed between C-17 and C-23, and
leads to the formation of a heterocyclic ring E. This can be proven by the fact that on
acetylation, the 3~, 29-diacetate is formed indicating only two free hydroxy groups.
The 13C NMR spectrum also shows the presence of two fully substituted alkene
carbon resonances at approximately 8 133.0-135.2 (133.1 ppm) and 133.1-137.0 ppm
(136.6 ppm). This double bond is placed between C-8 and C-9 and this can be proved
through the HMBC spectrum. This accounts for one of the eight double bond
equivalents expected in eucosterol, two more are assigned to the keto groups and the
five remaining double bonds equivalents are attributed to the pentacyclic ring
structure, including the heterocyclic ring E.
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The stereochemistry of the molecule can be confirmed through the NOESY spectrum.
The H-20 resonance gives positive NOESY correlations with the 3H-18, 3H-21, H-
22~ and H-25. From this it may be concluded that the stereochemistry ofH-20 is ~ or
R. The H-23 resonance shows correlations with H-22a and 3H-21. This indicates that
H-23 is a or S. The H-5a resonance shows correlations to H-3 and 3H-28. From this
it may be concluded that H-3 and 3H-28 (the unoxidised methyl group) are a. The
resonance ascribed to H-5 shows no correlation with H-19 which confirms that H-19
is ~ as expected. The 3H-21 and 3H-18 resonances shows a correlation with each
other, as a result of the C-17, C-20 bond being ~. The 3H-18 resonance shows no
correlation with 3H-30 resonance as expected.
The eucosterol derivatives isolated will be compared against this standard.
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2.5 The Biosynthesis of Triterpenoids
Terpenoids are built up from isoprene units.
isoprene
Figure 2.11: The isoprene unit, which is the basic building block of terpenoids
Isoprene (Figure 2.11) was first isolated more than one hundred years ago and
isoprene pyrophosphate (IPP) was found to be an essential component in the





Figure 2.12: Geraniol, a monoterpenoid formed from two isoprene units
The triterpenoids are considered to be derived from an acyclic precursor which is
cyclised and further elaborated to give different classes of compounds.27 This acyclic
precursor was found to be hexa-ene all-trans squalene and according to the Biogenetic
Isoprene Rule, different types of triterpenoids are formed according to the
conformation that squalene epoxide adopts, presumably at an enzyme surface, prior to
cyclisation.28,29 The precursor to squalene is two molecules of famesyl pyrophosphate
(FPp).30 FPP is synthesised from the reaction of geranyl pyrophosphate (GPP) and
IPP. The prenyl-tranferase reaction results in the formation of GPP. GPP is
28
synthesised from dimethylallyl pyrophosphate (DMAPP) and isopentyl
pyrophosphate (IPP) (Scheme 2.6).30 This reaction is catalysed by the enzyme prenyl
transferase.3o The reaction involves the ionisation of DMAPP to the allylic cation,
addition to the double bond ofIPP, followed by a stereospecific loss of a proton.30
I _ I _ ....... I electrophilic addition
~~pp-_.~ ~opriVlng tertlarlcat~'on~ +






Scheme 2.6: The formation of geranyl pyrophosphate9
Geranyl pyrophosphate can react with another molecule of isopentyl pyrophosphate to
form FPP, a fifteen-carbon compound (Scheme 2.7). This reaction proceeds in an
analogous manner to that of GPP.
I~ I~ -oPP- ~~j.". opp~n ~










Scheme 2.7: The formation offarnesyl pyrophosphate9
Two molecules of FPP are joined tail to tail to yield squalene (Scheme 2.8).30 A
proton from a C-I position of one molecule of FPP is lost and a proton from NADPH
is inserted.30 The mechanism involves the addition of the 2,3-double bond of FPP
onto the farnesyl carbocation similar to the chain extension of IPP. The tertiary
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carbocation formed then loses a proton, which results in the formation of the
cyclopropane ring, forming presqualene PP.30 The loss of pYrophosphate from
presqualene results in the formation of an unstable primary carbocation.3o This
carbocation then undergoes a Wagner-Meerwein rearrangement, which results in ring
expansion and the formation of a more favourable secondary carbocation.30 This is
then followed by bond cleavage of the cyclobutane ring, producing a favourable
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Scheme 2.8: The formation of squalene30
30






1loss of proton gives alkene
Lanosterol
Scheme 2.9: Proposed biosynthesis of lanosteroeo
Cyclization of squalene occurs through the intennediate squalene 2,3-oxide (Scheme
2.9).30 This reaction is catalysed by a flavoprotein requiring O2 and NADPH as
cofactors.3o The protonation of the epoxide group allows the opening of the epoxide
ring and the generation of the preferred tertiary carbocation, suitably placed to allow
electrophilic addition to a double bond.30 This process continues, generating a new
carbocation after each ring fonnation, until a tertiary protosteryl cation is fonned. 3o
The loss of a proton results in the fonnation of the double bond and subsequent proton
migrations result in the fonnation of lanosterol.30
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Nortriterpenoids are thought to be produced from the basic lanosterol skeleton. A
proposed biosynthetic pathway is illustrated below (Scheme 2.10) for the formation
of eucosterol type nortriterpenoids.
HO














Scheme 2.10: Proposed biosynthesis of eucosterol
32
2.6 The Biological Activity of Homoisoflavanones
Homoisoflavanones are known to be concentrated in the waxy, scale-like layers of
bulbs. 14 In this work, the homoisoflavanones were indeed isolated from bulb extracts.
Homoisoflavanones are known to possess anti-inflammatory, anti-mutagenic, anti-
bacterial and analgesic properties.31
Two well known homoisoflavanones, intracatin and intricatinol (Figure 2.13),
isolated from the roots of HofJmanseggia intricata (Fabaceae), have shown
antimutagenic properties.32t Both showed varying inhibition of mutagenicity in
Salmonella typhimurium of the carcinogens 2-amino-anthracene, acetylaminofluorine
and ethyl methanesulphonate.32 It was also shown that intricatinol, which possessed
two hydroxy groups, was more broadly active than intricatin, which possesses one
hydroxy groUp.32 This led to the postulation that increased potency could be








Figure 2.13 Intricatin and intricatinol
The anti-inflammatory properties of bulbs within the Hyacinthceae have been widely
investigated.33 The crude extracts from the bulbs ofMuscari comosum were tested for
anti-inflammatory properties, by using the inhibition of croton oil-induced dermatitis
in the mouse ear.33 Homoisoflavanone-rich fractions were shown to inhibit mouse
t Note that these homoisoflavanones from the Fabaceae have different ring A and B
oxidation patterns compared to that of the Hyacinthaceae.
33
dennatitis.33 The inhibitory effect obtained was comparable to that of the potent anti-
. fl dru . d th· 33In ammatory g, In ome aCIn.
Two homoisoflavanones isolated from Veltheimia bracteata (syn. V. viridifolia)
(Hyacinthceae) were tested against mixtures of phosphodiesterase (PPE) isozymes.34
The compound, 5-hydroxy-6,7,8-trimethoxy-3-(4'-hydroxybenzyl)-4-chromanone was
reported to possess a weak selective profile for PDE IV and PDE V.34 The study also
investigated the in vitro activity of the homoisoflavanone on leukotriene synthesis.34
A weak activity was reported for this system. The study also investigated the
bronchiospasmoloytic in vivo activity of the homoisoflavanone on the respiration and
on the cardiac system of guinea pigs.34 The results obtained indicated that the
compound induced a slight increase in the expiratory flow and a pronounced increase
in the respiratory rate in the test subjects.34 In addition, a moderated
bronchiospasmolysis was detected in conjuction with a decrease in heart rate.34 The
conclusions were that the homoiosflavanone had a weak and especially short
biological activity in the in vivo test systems.34
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2.7 The Biological Activity of Triterpenoids
The wide occurrence and the structural diversity of triterpenoids has long attracted
attention for the evaluation of their biological activities.
The relation between chemical structures and anticancer activity of some pentacyclic
and tetracyclic triterpenoids has been studied.35 The anticancer effects were tested
against human cancer celllines.35 Epimandiol, a pentacyclic triterpenoid was found to
be cytotoxic against HEC-I-A, CAMA-l, ME-180, u-87MG, CALAU-I and SK-OV-
3 celllines.35 Maniladiol, the 16~-epimer, exhibited cytotoxicity against ME-180 and
CAMA-l, whereas sophorradiol, which lacks a 16-hydroxy group, was cytotoxic only
against ME_180.35 This led them to the conclusion that the presence of a 16a.-hydroxy
group is important for the appearance of cytotoxicity of 12-0Ieanenes. Plumeric acid,
a nortriterpene acid and its methyl ester isolated from the leaves of Plumeric
acutifolia showed antitumor activity.35 The free acid at a concentration 25 ~g.mrl was
100% effective in inhibiting Yoshida sarcoma cells in vitro.35
Bioassay-directed fractionation of the cytotoxic antileukemic extracts of Prunella
vulgaris, Psychotria serpens and Hyptis capitata led to the isolation of ursolic acid as
one of the active principles.36 Ursolic acid showed significant cytotoxicity in the
lymphocytic leukemia cells P-388 and L-121O as well as the human lung carcinoma
cell A-549 cell line.36 It also demonstrated marginal cytotoxicity in the KB and human
colon (HCT-8) and mammary (MCF-7) tumor cells.36 Further investigations on the
cytotoxic fraction from the plant Hyptis capitata led to the isolation of two new and
three known triterpenoids.36 Hyptatic A and 2a.-hydroxyursolic acid demonstrated
significant in vitro cytotoxicity in human colon HeT-8 tumour cells.36
The anti-inflammatory activity of some triterpenoid derivatives of the oleanane series
was examined on the arachidonic (AA)-induced ear edema in mice.37 Of the
35
compounds examined the dihemiphthalate derivatives showed strong inhibition of ear
edema on both topical and oral administration. Topical 1Dso values were
approximately the same as nordihydroguaiaretic acid. Given topically these
compounds were also capable of inhibiting PGE2 and LTC4 formation at an early
stage of AA-induced ear edema. The most effective time for the topical administration
of the compounds against ear edema was found to be 0-30 minutes before AA
application. This is different from dexamethasone, which requires a time lag for
reaction.37 Pfaffic acid, a hexacyclic noriterterpene isolated from Pfaffia peniculata
also showed high inhibitory effects on the growth of cultured tumour cells, such as
melanoma (b-16), Hela (s-3) and Lewis lung carcinoma cells.38
No preVIOUS work has been done on the biological activity of eucosterol type
nortriterpenoids. This may be because of the very few occasions that they have been
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Chapter 3: Extractives from Ledebouria zebrina
3.1 Introduction
Ledebouria zebrina (Bak.) S. Venter belongs to the Hyacinthaceae (Liliaceae sensu lato)
Family, and is a member of the Hyacinthoideae subfamily. Members of this family are
widely distributed, but are particularly well represented in southern Africa and in the
region stretching from the Mediterranean to south-western Asia. l There are
approximately thirty species of Ledebouria in Africa and Asia, fifteen of which are
common in South Africa.2 Ledebouria was formerly included in the genus Scilla but has
now been independently classified.
Ledebouria zebrina (Figure 3.1) is distributed in South Africa throughout Mpumalanga
and Kwazulu Natal.3 It usually grows in moist, shaded conditions often associated with
forest vegetation. The bulbs have very characteristic purplish-brown outer scales which
are membranous.3
Plants of the Ledebouria genus are extensively used by traditional healers in Kwazulu-
Natal, particularly in enemas and as purgatives for both humans and catlle.4 Although
actual uses for Ledebouria zebrina have not been recorded, this species has recently been
identified in the Warwick Triangle ethnomedicinal plant market (Crouch 838, NH). Other
members of Ledebouria are used by traditional healers.4 Ledebouria revoluta is used by
the Sotho people as a charm to drive away lightning and for the treatment of lumbago.
Ledebouria cooperi is also used by the Sotho women during pregnancy and boys during
circumcision rites.4 Ledebouria ovatifolia is used for the treatment of gastro-enteritis and
in purgatives for adults.
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Figure 3.1: Ledebourill zebrina growing near Blyde Nature Reserve, Mpumalanga Photo: N.Crouch
This is the first reported phytochemical study of this plant. Both the dichloromethane and
methanol extracts of this plant were worked on. This led to the isolation of five
compounds (Figure 3.2), three homoisoflavanones and two nortriterpenoids, all isolated
from the dichloromethane extract. The methanol extract was difficult to work with
because the compounds present came out in mixtures that were very difficult to separate.
Of the five compounds isolated, three have not been reported previously. The compounds
isolated were 5,6-dihydroxy-7-methoxy-3-(4'-hydroxy-3'-methoxybenzyl)-4-chromanone
(I), 6-hydroxy-5,7-dimethoxy-3-(4'-hydroxy-3'-methoxybenzyl)-4-chromanone (11),
(22R,23S)-17a,23-epoxy-3P, 22, 29-trihydroxy-27-nor-Ianost-8-en-24-one (Ill), 5,7-












Figure 3.2: Compounds isolated from Ledebouria zebrina
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3.2 Results and Discussion
3.2.1 Structural elucidation of compound I, 5,6-dihydroxy-7-methoxy-3-(4'-
hydroxy-3'-methoxybenzyl)-4-chromanone (zebrina A)
OH 0
Figure 3.3: Structure ofzebrina A
Zebrina A (Figure 3.3), was isolated as an orange gum. This compound was found to
have a molar mass of 346.10575 g.mor l corresponding to a molecular formula of
C1sH1s07• From the molecular formula, a double bond equivalence of 10 was deduced.
The proton NMR spectrum of zebrina A [spectrum 1] showed the characteristic splitting
pattern of the 2H-2, H-3 and 2H-9 protons. This was indicative of a 3-benzyl-4-
chromanone-type of homoisoflavanone. Each of the H-2 protons was split by each other
and the H-3 proton and this resulted in a pair of double doublets at 3 4.10 ppm (7.0, 11.5
Hz) and 3 4.25 ppm (4.0, 11.5 Hz) assignable to the two H-2 protons. The same splitting
pattern was displayed by the interaction of H-3 and the two H-9 protons and the double
doublet resonances of the H-9 protons were found at 3 3.15 ppm (4.0, 13.7 Hz) and 3
2.67 ppm (lOA, 13.7 Hz). The H-3 proton was found to occur as a multiplet at S 2.79
ppm. The proton NMR spectrum also showed the presence of two methoxy group proton
resonances at 33.87 ppm and 33.90 ppm.
The appearance of an ABX system in the proton NMR spectrum with resonances at 3
6.71 (d, 2.0 Hz, H-2') ppm, 3 6.83 ppm (d, 8.2 Hz, H-5') and 3 6.69 ppm (dd, 8.2,2.0 Hz,
H-6') was indicative of the presence of three non-equivalent protons on the B ring and
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this also indicated that the B ring was 1',3', 4'-trisubstituted. One methoxy group and one
hydroxy group were attached to this ring as shown by the presence of a base peak of m/z
137 in the mass spectrum [spectrum 8] which corresponds to a hydroxy-methoxybenzyl /
tropylium ion (Scheme 3.1). The substitution pattern on this ring was deduced from the
NOESY spectrum [spectrum 7]. The NOESY spectrum showed a correlation between
the methoxy group proton signal at 8 3.87 ppm and the H-2' resonance at 8 6.71 ppm.
Thus the methoxy group was placed at C-3'. The H-6' and H-2' resonances showed
NOESY correlations with H-2a and H-2b. The assignment of H-2', H-5' and H-6' was
confirmed by coupling constants of 8.2 and 2.0 Hz, which are due to ortho coupling
between H-5' and H-6' and meta coupling between H-6' and H-2'. The hydroxy group was




A-4 • I + I
~ + ~
OCH3 HO H2C OCH3
OH °
m/z 210 m/z 137
tRDA AND H-SHIFT
It
m/z 182 m/z 183
Scheme 3.1: Fragmentation pattern ofzebrina A9
The substitution pattern on the A-ring could be deduced from the mass, IH NMR and DV
spectra. The appearance of a singlet integrating to one proton at 86.00 ppm (usually due
to H-6 or H-8) in the proton NMR spectrum indicated that there was only one
unsubsituted position on the A ring. The existence of a peak at m/z 210 in the mass
spectrum was evidence of a dihydroxy-methoxychromanone fragment ion (Scheme 3.1).9
This implied that the A-ring contained two hydroxy and one methoxy groups. The
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methoxy group was assigned to the C-7 position due to no bathochromic shift in the DV
spectrum [spectrum 10] when NaOAc was added.5,6 One hydroxy group was assigned to
the C-5 position due a bathochromic shift of 27 nm in the DV spectrum [spectrum 11]
with AICh.5,6 The downfield signal due to a hydroxy group proton (0 11.78) was assigned
to the proton of the strongly hydrogen-bonded 5-hydroxy group.? This was confirmed by
the downfield shift of the carbonyl group (0 198.7) that becomes deshielded due to the
chelating effects with the hydroxy group at C-5. Placement of the second hydroxy group
was difficult since it could be placed at positions C-6 or C-8. Since no NOESY
correlation could be seen between the hydroxy group proton at C-5 and this proton,
which would have indicated that the proton was at C-6 instead, the second OH group was
placed at position C-6 and the proton at C-8.
The structure was confirmed using the HMBC spectrum [spectrum 5]. The HMBC,
COSY and NOESY data are provided in Table 3.1.
The infrared data [spectrum 12] supported the postulated homoisoflavanone structure for
zebrina A. Peaks were observed at 3460 cm-1 (O-H stretching), 2927 cm-1 (aliphatic C-H
stretching), 1653 cm-1 (C=O stretching), 1514 and 1444 cm-1 (aromatic C=C stretching).
A literature search for the compound indicated that it was novel and it was named zebrina
A (5,6-dihydroxy-7-methoxy-3-(4'-hydroxy-3'-methoxybenzyl)-4-chromanone).
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Acetylation of zebrina A, yield a triacetate derivative (zebrina acetate), confirming the
presence of three hydroxy groups in the original structure.
Figure 3.4 Structure of zebrina acetate
The IH NMR spectrum [spectrum laJ of zebrina acetate [Figure 3.4J had a three-proton
singlet and a six-proton singlet at 8 2.28 and 2.29 ppm respectively which was indicative
of three acetate methyl groups. The singlet proton for ring A was shifted upfield to 8 6.40
ppm. The H-S' resonance was also shifted upfield to 86.96 ppm. The l3C NMR spectrum
[spectrum 2aJ showed additional resonances for the acetate carbonyls (8 168.2, 168.5
and 169.1 ppm) and methyl resonances (8 20.2, 20.7 and 20.8 ppm) compared to zebrina
A. The infrared spectrum [spectrum 12aJ showed no O-H stretching confirming that all
the hydroxy groups were converted to acetate groups but an extra carbonyl stretch band at
1765 cm-1 attributable to the extra ester carbonyl groups.
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Table 3.1: IH, BC, HMBC, COSY and NOESY data for 5,6-dihydroxy-7-methoxy-3-
(4'-hvdroxv-3'-methoxvbenzyl)-4-chromanone (CDCh)
Carbon IH l3C HMBC~H COSY NOESY
(ppm) (ppm)
2 H-2a-4.25 (dd,4.0, 11.5) 69.3 H-9a,b;H-3 H-2b;H-3 H-3;H-2b
H-2b-4.10 (dd,7.0,11.5) H-2a;H-3 H-6';H-3;H-
2a;H-9b
3 2.80 (m) 47.1 H-9a,b;H-2 b H2a,b; H-2a,b;H-
H-9a,b 9a,b;H-2'





8 6.00 (8) 91.0 7-0CH3 7-0CH3 7-0CH3
8a 156.0 H-2a;b;H-8
9 H-9a-3.15 (dd,4.0,13.7) 32.5 H-2a,b;H-2' H-9a;H-3; H-9b;H-3;H-2'
H-9b-2.67 (dd,10.4,13.7) H-9b;H-3 H-9a;H-3;H-
2';H-2b
l' 129.6 H-9a,b;H-5';H-3





5' 6.83 (d,8.2 Hz) 114.4 H-6' H-6'
6' 6.69 (dd,8.2, 2.0 Hz) 121.9 H-9a,b;H-3;H-2' H-5' H-3; H-2b
7-0CH3 3.90 (8) 56.3 H-8 H-8
3'-OCH3 3.87 (8) 55.9 H-2' H-2'
5-OH 11.78(8)
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3.2.2 Structural Elucidation of Compound 11, 6-hydroxy-5,7-dimethoxy-3-(4'-
hydroxy-3'-methoxybenzyl)-4-chromanone (zebrina B)
This compound was isolated as an amorphous gum and was found to be novel.
Figure 3.5: Structure of zebrina B
Zebrina B (Figure 3.5) also belongs to the 3-benzyl-4-chromanone type of
homoisoflavanones. The resonances observed for 2H-2, H-3 and 2H-9 in the IH NMR
spectrum [spectrum 13] were similar to those ofzebrina A.
Inspection of the mass spectrum [spectrum 20] revealed a parent ion at, m/z 360.12137
g.mor1, which corresponded to a molecular formula of C19H2007, and was consistent with
the proposed homoisoflavanone structure. Intense signals were observed at m/z 137 and
224 due to A-4 fragmentation. The fragment at m/z 224 suggested that ring A had one
hydroxy and two methoxy substituents and the hydroxy-methoxybenzyl / tropylium ion at
m/z 137 similarly suggested that the B ring had one hydroxy and one methoxy group as
substituents. The signal at m/z 197 is typically formed via the retro-Diels Alder cleavage


















Scheme 3.2: Fragmentation pattern ofzebrina B9
The infra-red data [spectrum 24J supported the homoisoflavanone structure for zebrina
B. Peaks were observed at 3430 cm-1 (O-H stretching), 2930 cm-1 (aliphatic C-H
stretching), 1619 cm-1 (C=O stretching), and 1521 cm-1 (aromatic C=C stretching).
The aromatic regIOn of the IH NMR spectrum confirmed the substitution patterns
indicated by the mass spectrum. The aromatic ABX system with resonances at 8 6.68 (dd,
8.0, 1.9 Hz, H-6'), 8 6.72 (d, 1.9 Hz, H-2') and 8 6.82 (d, 8.0 Hz, H-5') ppm, confirmed
the substitution pattern of the B ring and was similar to that of zebrina A. The NOESY
spectrum [spectrum 19] showed a correlation between a methoxy group proton
resonance and the proton at C-2'. Thus, the methoxy group was placed at C-3' and the
hydroxy group at C-4'. The remaining aromatic signal in the spectrum was a singlet
resonance (integrating to one proton) at 8 6.26 ppm. This confirmed the type of
substituents on the A ring, that had been suggested by the mass spectrum. One of the
methoxy groups was assigned to the C-5 position due to the lack of a bathochromic shift
in the DV spectrum [spectrum 23J with AlCh.5,6 The other methoxy group was assigned
to the C-7 position due to no bathochromic shift in the DV spectrum [spectrum 22J when
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NaOAc was added.5,6 Placement of the hydroxy group was done through the HMBC
spectrum [spectrum 17]. The resonance ascribed to C-8a (D 157.1 ppm) shows a HMBC
correlation with the aromatic proton at D 6.26 ppm and this is more likely to be a 2)
correlation with the proton at C-8 than a 4) correlation with the proton at C-6. The
hydroxy group is therefore placed at C-6.
These assignments were confirmed by the HMBC, NOESY and COSY spectra and are
listed in Table 3.2. This is the first report of this structure and it was called zebrina B (6-
hydroxy-5,7-dimethoxy-3-(4'-hydroxy-3'-methoxybenzyl)-4-chromanone.
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Table 3.2: IH, l3C, HMBC, COSY and NOESY data for 6-hydroxy-5,7-dimethoxy-3-
(4'-hydroxy-3'-methoxybenzyl)-4-chromanone (CDCh)
Carbon IH l3C HMBC~C COSY NOESY
(ppm) (ppm)
2 H-2a-4.01 (dd,7.1,II.4) 69.1 H-2b;H-3 H-3;H-6';H-2b
H-2b-4.25 (dd,3.9,11.4) H-2a;H-3 H-2a;H-3








8 6.26 (s) 95.9 7-0CH3 7-0CH3
8a 157.1 H-2a,b;H-8
9 H-9a-.63(dd, 10.6,13.4) 32.6 H-9b;H-3 H-9b;H-2'
H-9b-3.14 (dd,3.7,13.4) H-9a;H-3 H-9a;H-3;H-2'
l' 130.2 H-9a,b




5' 6.82 (d,8.0) 114.3 H-6' H-6'
6' 6.68 (dd,8.0, 1.9) 111.4 H-9a,b H-5' H-5';H-2a
3'-OCH3 3.86 (s) 55.9 H-2'
5- OCH3 3.92 (s) 61.7
7- OCH3 3.90 (s) 56.3 H-8 H-8
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3.2.3 Structural Elucidation of Compound Ill, (22R,23S)-17a,23-epoxy-3~,22,29­
trihydroxy-27-nor-lanost-8-en-24-one (22~-hydroxy-15-deoxoeucosterol)
This was the third compound isolated during the course of this work. It was isolated as
white crystals with a melting point between 233-236°C.
Figure 3.6: Structure of 22~-hydroxy-15-deoxoeucosterol
The compound (Figure 3.6) isolated was a derivative of 15-deoxo-eucosterol-type
nortriterpenoids. The mass spectrum [spectrum 31] did not show a molecular ion peak
but showed an M+-H20 peak at m/z 456 g.mor
1
• The molecular formula was found to be
C29~605-from the mass spectrum in conjunction with the NMR spectra. From the
molecular formula a double bond equivalence of seven was deduced.
The proton NMR spectrum [spectrum 25] showed the presence of the same number of
methyl group proton resonances as found in eucosterol (six methyl groups). The spectrum
showed an extra doublet at 8 4.26 ppm, which corresponded to a proton attached to the
same carbon as an oxygen. This resonance showed a COSY [spectrum 29] correlation
with H-23. This implied that a secondary hydroxy group was present at C-22. This
resonance also showed a NOESY correlation with H-23 and 3H-21 and this implied that
H-22 was a and the hydroxy group was ~. This assignment was confirmed through the
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HMBC spectrum [spectrum 28], which showed a 3J correlation from C-17 to H-22. This
compound was found to lack the keto group at C-15 present in eucosterol. This was
determined through the HMBC spectrum. The HMBC spectrum showed a 3J correlation
from the only carbonyl group (8 213.9 ppm) present to the methyl group proton triplet
assigned to 3H-26 (8 1.06 ppm) indicating that the carbonyl group was at C-24 and not at
C-15. The rest of the structure was similar to eucosterol. The HMBC, COSY and NOESY
data that were used to confirm the structure are shown in Table 3.4.
The infrared spectrum [spectrum 32] showed a broad signal at 3420 cm-!, which
accounted for the presence of hydroxy group stretching, a sharp peak at 1720 cm-! which
indicated the presence of a ketone carbonyl group. A strong peak at 2933 cm-! indicated
the presence ofC-H stretching.
Finally a literature search for the compound was done. It was found to be (22R,23S)-
17a,23-epoxy-3~,22,29-trihydroxy-27-nor-Ianost-8-en-24-one a compound previously
isolated from Scilla scilloides.!O In order to confirm the structure the carbon data were
compared with those from literature. The reference compound, however, was run in
deuterated pyridine while compound III was run in deuterated methanol. To confirm that
the NMR data was identical, compound III was re-run in deuterated pyridine [spectrum
33] to get a better comparison with literature values. The 13C NMR data of compound III
and those of the reference compound (Table 3.3) corresponded very well. From this it
was concluded the compound III was (22R,23S)-17a,23-epoxy-3~,22, 29-trihydroxy-27-
nor-lanost-8-en-24-one.
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Acetylation of compound Ill, yield a triacetate derivative (IlIA), confirming the presence





Figure 3.7: Structure of Compound IlIA
The IH NMR spectrum [spectrum 25aJ of IlIA [Figure 3.7J had an extra three three-
proton singlets at 8 1.96,2.01 and 2.03 ppm, which indicated three acetate methyl groups.
The H-3 and H-22 resonances were shifted downfield to 8 4.55 and 5.12 ppm
respectively. The H-29 protons were shifted downfield to 84.16 and 4.32 ppm. The l3C
NMR spectrum [spectrum 26aJ showed additional resonances for the acetate carbonyl
carbons (8 169.9, 170.6 and 171.1 ppm) and methyl resonances (8 21.4, 21.3 and 21.2
ppm) compared to compound Ill. The infrared spectrum [spectrum 32aJ showed no O-H
stretching confirming that all the hydroxy groups were converted to acetate groups.
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CARBON l3C NMR data for l3CNMR
































Table 3.4: IH, 13C, HMBC, COSY and NOESY data for (22R,23S)-17a.,23-epoxy-
3f3,22,29-trihvdroxy-27-nor-Ianost-8-en-24-one (CD3OD)
IH 13C HMBC--+H COSY NOESY
(ppm) (oom)
1 H-l 0.-1.81 (m) 36.8 3H-19 H-5
H-l-f3-1.83 (m)
2 1.75 (m) (2H) 29.0 H-l H-3
3 # 81.4 3H-28 H-2
4 43.7 3H-28;H-29
5 1.22 (m) 52.9 3H-19;3H-28 H-6 H-l
6 1.51 (mHH-2) 19.7 3H-28 H-5




11 2.14 (m) (2H) 21.9 H-12 3H-18;3H-30;H-12
12 1.53 (m) (2H) 26.4 3H-18 H-11 3H-21;H-20;3H-18
13 51.2 3H-18;3H-30
14 51.3 3H-18;3H-30
15 H-15a.-1.40 (m) 33.2 3H-30 H-16a.,P 3H-30
H-15f3-1.74 (m) H-16a.,f3 3H-18
16 H-16a.-2.42 (m) 41.0 H-15a.,P
H-16[3-2.15 (m) H-15a.,f3 3H-18
17 98.7 3H-18;3H-21;
H-22
18 1.00 (s) 20.1 3H-21 ;H-20;H-12;H-
16f3
19 1.04 (s) 20.2 H-5 H-l;H-ll;H-12
20 2.30 (m) 53.1 3H-21 3H-21 3H-21 ;3H-18;H-20
21 1.10 (d)* 16.3 H-22 H-20 H-12;3H-18
22 4.26 (d,4.9) 81.9 3H-21 H-23 H-23;3H-21
23 4.64 (d,5.9) 88.5 H-22;H-20 H-22 H-22;3H-21
24 213.9 H-23;3H-26;
H-25
25 2.56 (Q,7.3) 34.4 3H-26 3H-26 H-25
26 1.06 (t)* 7.4 H-25 H-25 H-26
28 1.25 (s) 23.1 H-29a H-5;H-l
29 H-29a-3.41(d,I1.3) 65.2 3H-28;H-5 H-29b H-19;H-29b
H-29b-4.20(d, 12.0) H-29a H-29a
30 1.29 (s) 26.6 H-15a.;H-20
#-peak obscured by solvent peak
*-peaks obscured, J values could not be detennined
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Figure 3.8: Structure of zebrina C
Zebrina C (Figure 3.8) was isolated as a yellow gum and was found to be novel. This
compound was found to have a molar mass of 316.09462 g.mor1 corresponding to a
molecular formula of C17HI606. From the molecular formula, a double bond equivalence
of 10 was deduced. This compound also belonged to the 3-benzyl-4-chromanone type of
homoisoflavanones. The proton NMR spectrum [spectrum 34] of compound IV showed
the characteristic splitting pattern of the 2H-2, H-3 and 2H-9 as was seen in zebrina A
andB.
The appearance of an ABX system in the IH NMR spectrum with resonances at B 6.78
ppm (d, 8.2 Hz, H-5'), B6.79 ppm (d, J =2.0Hz, H-2') and B 6.69 ppm (dd, J=8.2, 2.0Hz,
H-6') was similarly to that of zebrina A and B indicative of the presence of three non-
equivalent protons on the B ring. A methoxy group and a hydroxy group were attached to
this ring as shown by the presence of a base peak of m/z 137 in the mass spectrum
[spectrum 41] which corresponds to a hydroxy-methoxybenzyl / tropylium ion (Scheme
3.2).
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Figure 3.9: Comparision of the B ring in zebrina C and 5-hydroxy-6,7-dimethoxy-3-(4'-hydroxy-3'-
methoxybenzyl)-4-chromanone (XX)
The substitution pattern of ring B in zebrina C could not be detennined through the
NOESY spectrum [spectrum 40] as was done in zebrina A and B because the proton
resonances of H-5' and H-2' overlapped. The substitution pattern on this ring was
therefore deduced by comparing chemical shift values of zebrina C and 5-hydroxy-6,7-
dimethoxy-3-(4'-hydroxy-3'-methoxybenzyl)-4-chromanone (Figure 3.9, Table 3.5).11 In
this comparison particular emphasis was placed on the resonances of C-1', C-2', C-3', C-
4', C-5', C-6'. The chemical shift values compared quite favourable which led us to assign
the resonance at () 145.4 ppm to C-3' and that at () 145.7 ppm to C-4'. The HMBC
spectrum [spectrum 38] showed a 3J correlation from C-3' to the methoxy group. The
methoxy group was placed at C-3' and the hydroxy group at C-4'. To confinn this
substitution pattern a ROESY spectrum [spectrum 40a] was run but this also proved to



















Scheme 3.3: Fragmentation pattern of zebrina C9
The substitution pattern of the A-ring could be deduced from the mass, lH and DV
spectra. The existence of a peak at m/z 180 in the mass spectrum was evidence of a
dihydroxychromanone fragment ion (Scheme 3.3). This implied that the A-ring contained
two hydroxy groups. One hydroxy group was assigned to the C-5 position due a
bathochrornic shift of 29 nrn in the DV spectrum [spectrum 44] with AICh.5,6 The
downfield signal due to a hydroxyl group proton (0 11.78 ppm) was assigned to the
strongly hydrogen-bonded 5-hydroxy groUp.3 This was confinned by the downfield shift
of the carbonyl group that is deshielded due to the chelating effects with the hydroxy
groUp.l,2 The second hydroxy group was placed at C-7 due to a bathochrornic shift of21
nrn in the DV spectrum [spectrum 43] with NaOAc.5,6 The appearance of two meta-
coupled doublets in the lH NMR spectrum, each integrating to one proton, at 0 5.89 and
5.96 ppm were assigned to H-6 and H-8 respectively. The HMBC, COSY and NOESY
data are presented in Table 3.6.
The infrared data [spectrum 45] supported the proposed homoisoflavanone structure for
zebrina C. Peaks were observed at 3379 cm'l (O-H stretching), 2921 cm'l (aliphatic C-H
stretching), 1636cm·l (C=O stretching), 1522 and 1448 cm'l (aromatic C=C stretching).
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A literature search for the compound indicated that it was novel and it was named zebrina
C (5,7-dihydroxy-3-(4'-hydroxy-3'-methoxybenzyl)-4-chromanone).
Table 3.5: Comparison of the chemical shift values of ring B, of zebrina C with 5-
11hydroxy-6,7-dimethoxy-3-(4'-hydroxy-3'-methoxYbenzyl -4-chromanone .(CDCi])
Carbon l3C NMR data for 13CNMR









Table 3.6: tH, 13C, HMBC, COSy and NOESY data for 5,7-dihydroxy-3-(4'-
hydroxy-3'-methoxybenzyl)-4-chromanone (CDC!J)
Carbon tH 13C HMBC~H COSY NOESY
(ppm) (ppm)
2 H-2a-4.25 (dd,4.2,11.5) 69.0 H-9a,b H-2b;H-3 H-3;H-2b
H-2b-4.10 (dd,7.1,11.5) H-2a;H-3 H-3;H-2b
3 2.79 (m) 46.6 H-9a,b; H-2a,b; H-2a,b;H-






6 5.96 (d,2.2) 96.6 H-8;5-0H
7 164.3 H-6;H-8
8 5.89 (d,2.2) 95.0 H-6
8a 163.2 H-2a,b;H-8
9 H-9a-2.63 (dd,10A,3.3) 31.9 H-2 a,b;H-6' H-3;H-9b H-2';H-3;H-9b;
H-6'
H-9b-3.13 (dd,4A, 13.9) H-9a;H-3 H-2';H-3 ;H-9b;
H-6'
I' 131.0 H-9a,b




5' 6.78 (d,8.2) 110.8 H-6' H-6'
6' 6.69 (dd,8.2,2.0) 120.6 H-9a,b;H-2' H-5' H-9a,b;H-3;H-
5'
3'-OCH3 3.86 (s) 56.0 H-2'
5-0H 12.11 (s)
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3.2.5 Structural Elucidation of V, (23S)-17a.,23-epoxy-3~,28,29-trihydroxy-27­
norlanost-8-en-24-one
This compound was isolated as an orange gum.
o
Figure 3.10: Structure of Compound V
The mass spectrum [spectrum 53] showed a molecular ion peak at m/z 474.33398 g.
mor l which corresponded to a molecular formula of C29~605. From this a double bond
equivalence of seven was deduced. This compound was found to be another derivative of
eucosterol type nortriterpenoids (Figure 3.8).
The I H NMR spectrum [spectrum 46] showed the presence of five methyl groups in the
molecule compared with six found in eucosterol. The methyl group protons of 3H-26 and
3H-21 were not easily recognized in this spectrum because they were superimposed at 8
1.04 ppm. This was illustrated through the HSQC spectrum [spectrum 49], which
showed two methyl group carbons correlating to the resonance at 8 1.04 ppm. The
HMBC spectrum [spectrum 50] showed 3Jcorrelations from both C-17 and C-24 to the
resonance 8 1.04 ppm indicating the presence of the 3H-26 and 3H-21 proton resonances
at 8 1.04 ppm. The remaining four methyl group protons in eucosterol, the standard
compound, all appear as singlets but there were only three methyl group singlets in
compound V. The one absent in compound V was again determined through the HMBC
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spectrum. The HMBC spectrum showed a 3J correlation from C-17 to the methyl group
proton singlet at 80.86 ppm. This methyl group proton resonance was assigned to 3H-18.
The HMBC spectrum also showed a 3J correlation from C-9 to a methyl group proton
singlet at 8 0.92 ppm. This was assigned to the methyl group protons at C-19. The
HMBC spectrum further showed a 3J correlation from C-8 to the remaining methyl group
proton singlet at 8 1.19 ppm. This was assigned to the methyl group protons at C-30. This
implied that no methyl groups occurred at C-4.
The 13C NMR spectrum [spectrum 47] did not show the ketone resonance for C-15
found in eucosterol: instead it showed the presence of an extra methylene group carbon
for C-15. The 1H NMR spectrum showed the presence of an extra oxygenated methylene
group (8 3.75, 4.13 ppm) compared to eucosterol. This primary hydroxy group was
placed at C-28. This placement was confirmed through the HMBC spectrum. The HMBC
spectrum showed 3J correlations from C-3 to the usual C-29 hydroxy methyl group (8
3.73,4.13 ppm, ea d, 11.2 Hz) and this second hydroxy methyl group (8 3.73,4.33 ppm,
ea. d, 11.5 Hz). This indicated that both methyl groups at C-28 and C-29 had been
oxidised to alcohols. Table 3.8 shows the HMBC, COSY and NOESY data for
Compound V.
The infrared data [spectrum 54] supported the proposed structure. Peaks were observed
at 3437 cm-I (O-H stretching) 2929 cm-I (aliphatic C-H stretching) 2853 cm-I (C-H
stretching) and 1731 cm-I (C=O stretching).
Finally a literature search of the compound was undertaken. It was found to be (238)-
17a,23-epoxy-3P,28,29-trihydroxy-27-norlanost-8-en-24-one, a compound previously
isolated from Muscari comosum (Hyacinthaceae). 12 A comparison was made with the 13C
NMR data with the compound from literature. Table 3.7 shows the carbon comparison of
compound V and literature values. 12 The carbon data compares favorably. Compound V
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was therefore deduced to be (235)-17a,23-epoxy-3~,28,29-trihydroxy-27-norlanost-8-en­
24-one.
Table 3.7: Comparison of BC NMR data of compound V with (23S)-17a,23-epoxy-
123B,28,29-trihvdroxv-27-norlanost-8-en-24-one (CDCh)
CARBON 13C NMR data for 13CNMR
































Table 3.8: IH, 13C, HMBC, COSY and NOESY data for (23S)-17a.,23-epoxy-
3l3,28,29-trihYdroxy-27-nor-lanost-8-en-24-one (CDCh
IH l3C HMBC~H COSY NOESY
(ppm) (ppm)
1 1.72 m) (2H) 35.2 3H-19 3H-19
2 1.76 m)(2H) 27.3 H-1 H-3 3H-19
3 3.72 m) 77.6 H-28;H-29 H-2 H-28
4 45.8 H-5
5 1.25 m) 47.0 3H-19;H-28;H-29 H-6 H-7
6 1.46 m) (2H) 18.6 H-5 3H-19




11 H-11a-2.12 (m) 20.7 H-12a,p
H-11~-1.94(m) H-12a,~ 3H-19,H-12a,p
12 H-12a-1.38 (m) 24.8 3H-18 H-lla,p
H-12B-2.18 (m) H-11a,p 3H-21;3H-18
13 48.5 3H-18;3H-30
14 50.4 3H-18;3H-30
15 H-15a-1.60 (m) 31.6 3H-30 H-16a,p 3H-30
H-15B-1.32 (m) H-16a,~ H-16P
16 H-16a-2.15 (m) 39.6 H-15a,p
H-16B-1.60 (m) H-15a,~ H-20,3H-21,3H-18,H-15P
17 97.0 3H-18;3H-21;
H-22;H-22
18 0.86 (s) 19.4 3H-21 3H-21;H-20;H-12P;H-
16P
19 0.92 (s) 19.1 H-29b;H-6;H-1 ;H-7
20 2.14 43.5 3H-21 3H-21 3H-18;H-16B
21 1.04 (d)* 17.1 H-22 H-20 3H-18·H-23·H-12B, ,
22 1.78 36.7 3H-21 H-23 H-23;3H-21,
23 4.64 (dd,7.3, 10.4) 81.4 H-22 H-22;3H-21 ;H-25
24 213.6 3H-26
25 2.53 (Q, 7.33) 32.2 3H-26 3H-26 H-23;H-26
26 1.04 (t)* 7.4 H-25 H-25 H-25a
28 28a-3.75 (d, 11.2) 70.9 H-5;H-29a H-28; H-28a,b
28b-4.13 (d,11.2) H-28b
29 29a-3.75 (d,11.5) 63.6 3H-28;H-5;H-3 H-29a; 3H-19;H-29a,b
29b-4.33 (d, 11.5) H-29b
30 1.19 (s) 25.8 3H-18 H-15a;H-16B
*-peaks obscured, J values could not be detenmned
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3.3 Test for Anti-fungal Properties
Homoisoflavanones are often cited in the literature (Section 2.6) as having anti-fungal
properties.4,13-15 Accordingly a simple test for the antifungal activity was performed on
zebrina A, zebrina B and compound Ill. Fusarium moliniforme was chosen as the fungus
since it is a very common strain found to infect seeds and developing plants.
The three compounds were spotted on a TLC plate and incubated for 7 days after
application of the prepared fungal spray. The assay was then stained with Tinopal
solution and viewed under DV light at 254 nm.
Zebrina A and B did not show anti-fungal activity, as a substantial amount of fungal
mycelia was evident on and around the applied compounds. Compound Ill, the eucosterol
type-nortriterpenoid, showed the most promising results with no fungal growth within 8
mm of the point of application.
Further tests are still to be carried out in a collaborating laboratory.
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3.4 Foreword to Experimental
3.4.1 Nuclear Magnetic Resonance Spectroscopy (NMR Spectroscopy)
Nuclear magnetic resonance spectroscopy was carried out on either a 400 MHz Varian
UNITY-INOVA spectrophotometer or a 300MHz Gemini spectrophotometer. The
spectra of compound III were run at a temperature of 60°C in deuterated methanol
(CD30D). All other spectra were recorded at room temperature in either deuterated
chloroform (CDC!)), deuterated methanol (CD30D), deuterated pyridine (CsDsN) or
deuterated dimethylsulphoxide (DMSO). The chemical shifts were all recorded in ppm
relative to TMS. The ROESY spectrum was run on a 500 MHz Varian UNITY-INOVA
spectrophotometer by Mr Martin Watson from the University of Natal, Pietermaritizburg.
3.4.2 Infrared Spectroscopy (I.R. Spectroscopy)
The infra-red spectra were recorded using a Nicolet Impact 400D Fourier-Transform
Infra-Red (Ft-IR) spectrometer. The crystalline compounds were analysed using KBr
discs and the non-crystalline samples were dissolved in dichloromethane and analysed on
a sodium chloride window. The spectra were calibrated against an air background.
3.4.3 Ultraviolet Absorption Spectroscopy (U.V. Spectroscopy)
The ultra-violet absorption spectra were obtained on a Varian DMS 300 DV-visible
spectrometer. The solvent in which the spectra were recorded was dichloromethane. The
NaOAc and AIC!) solutions used for bathochromic shifts were prepared by dissolving
0.5g of each salt (anhydrous) in 100 ml volumetric flasks with methanol.
3.4.4 Melting Points
Melting points for crystalline compounds isolated were determined on an Emst Leitz
Weltzlar melting point apparatus and are uncorrected.
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3.4.5 Mass Spectrometry
High resolution mass spectra were recorded for all novel compounds on a Kratos 9/50
HRMS instrument. The mass spectrometry was performed by Dr. P. Boshoff at the Cape
Technikon. All other mass spectra were recorded on an Agilent MS 5973 instrument
connected to a GC 6890 by Mr B. Parel.
3.4.6. Optical Rotations
Optical rotations were measured at room temperature in chloroform using either a Optical
Activity AA-5 Polarimeter together with a series A2 stainless steel (4x200 mm)
unjacketed flow tube or a Perkin Elmer 241 Polarimeter with a 10 cm flow tube.
3.4.7 General Chromatography
The isolation process involved column and thin layer chromatographic techniques. In
column chromatography, different sized columns were used ranging from 2-8 cm in
diameter depending on the amount of sample available and the purification stage.
Separation of crude extracts was generally carried out on a column using Merck Art.
9385 silica gel. Final purifications were found to be most successful when use was made
of open 0.75 cm diameter Pasteur pipettes as columns. All separations were carried out
under gravity. Both the column and thin layer techniques made use of varying ratios of
dichloromethane, ethyl acetate and hexane. Thin layer chromatography was carried out
on 0.2 mm silica gel, aluminium-backed plates (Merck Art. 5554). The plates were first
viewed under UV and then developed using an anisaldehyde: conc. H2S04: methanol
[1:2:97] spray reagent. The plates were first analysed under DV light (366 run) and then
heated.
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3.4.8 Preparative Thin Layer Chromatography (PTLC)
Compounds which were visible under DV light were isolated using this technique. The
aluminium-backed plates (Merck Art. 5554) were lined with the extract sample 1 cm
from the bottom of the plate. The plates were loaded by dipping a capillary tube in the
extract solution and allowing it to run onto the silica gel by touching it to the plates. The
plates were then developed in a chromatography tank and the compound of interest was
detected using DV light. The marked portion was cut out and boiled in methanol and
dichloromethane.
3.4.9 Acetylation Procedure
Pyridine (1 ml) and acetic anhydride (1 ml) were added to the sample (20 mg) in a round-
bottomed flask. The sample was left to stand for 48 hours. Methanol (5 ml) was then
added to the sample to react with the excess acetic anhydride, and toluene (4xlO ml) was
added successively to remove pyridine. After each addition, the solvent was evaporated
off on a rotovapor. Thereafter, methanol (5xlO ml) was added to remove the toluene. The
sample was then spotted on a TLC plate to see whether the reaction had gone to
completion or needed to be purified.
3.4.10 Anti-Fungal Assay
Fusarium moliniforme was isolated from Trichila dregeana seeds and subcultured on
PDA (PDA (25g), Bactoagar (15g), NaCl (30g) and distilled water (900 ml) in sealed
petri dishes. The fungus was incubated for 20 days. A plastic ice-cream container was
sterilized with 100% ethanol and allowed to dry. The three compounds of interest were
dissolved in dichloromethane and spotted onto a TLC plate (1.5 cm apart) using capillary
tubes. The plate was left to stand until the solvent had completely evaporated.
A spore suspension was prepared by flooding the petri dishes with 500 rnl of nutrient
solution [glucose and mineral solution (1: lO)].
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Mineral solution: KH2P04 (7 g), NaHP04.H20 (3 g), KN03 (4 g), MgS04.7H20 (I g),
NaCI (1 g) and tap water (1000 ml)
Glucose solution: 30% (m/v) glucose solution
The nutrient solution was poured into a spray bottle and sprayed evenly over the TLC
plate. This was placed in the ice-cream container along with moist, sterile paper and
sealed. The chamber was incubated at 25°C for 7 days.
The plate was subsequently sprayed with Tinopal solution in phophate buffer (as
described below) at pH of 8 and viewed under a DV light at 254 nm.
Tinopal solution: Na2HP04 (7.1 g) was dissolved in distilled water (500 ml) to create a
O.IM solution. NaH2P04 (1.56 g) was dissolved in distilled water (100 ml) to create a
O.IM solution. The Mettler Toledo MP 230 pH meter was calibrated using pH 4 and pH 7
standards. The Na2HP04 solution, containing a magnetic bead, was placed on a magnetic
stirrer and the pH electrode was placed in the solution. The Na2HP04 solution was added
dropwise until a pH of 8 was obtained. A volume of 300 ml of this buffer was decanted
into a spray bottle, to which 0.15 g of Tinopal UNPA-GX (C4oH«N120IOS2) was added.
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3.5 Experimental
Dr Neil Crouch of the National Botanical Institute collected the plant material from a
swamp in the Blyde Nature Reserve, in Mpumalanga and a voucher specimen was
retained at the Natal Herbarium (N. Crouch 860 NH). The part of the plant investigated
was the bulbs. The bulbs (4.495 kg) were chopped into small pieces, air dried for
approximately 48 hours and then extracted successively with dichloromethane (mass of
extract-25.23g) and methanol (mass of extract-369.93g) by agitation on a Labcon
Mechanical shaker at 140rpm. Extraction with each solvent was carried out for
approximately 72 hours. The extracts obtained were then filtered and the solvent was
removed using a BUCHI rotavapor. General chromatographic techniques were employed
(Section 3.4) and this led to the isolation of five compounds: 5,8-dihydroxy-7-methoxy-
3-(4'-hydroxy-3'-methoxybenzyl)-4-chromanone (I) (32 mg), 6-hydroxy-5,7-dimethoxy-
3-(4'-hydroxy-3'-methoxybenzyl)-4-chromanone (11) (16 mg), (22R,23S)-17a,23-epoxy-
3~, 22, 29-trihydroxy-27-nor-Ianost-8-en-24-one (Ill) (46mg), 5,7- dihydroxy-3-(4'-
hydroxy-3'-methoxybenzyl)-4-chromanone (IV) (13 mg) and (23S)-17a,23-epoxy-
3~,28,29-trihydroxy-27-nor1anost-8-en-24-one (V) (50 mg).
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3.5.1 Physical data for Compound I
Name: 5,6-dihydroxy-7-methoxy-3-(4'-hydroxy-3'-methoxybenzyl)-4-chromanone
(zebrina A)
Yield: 32 mg, 20 mg was used for the acetylation
Physical Description: orange gum
Optical rotation: [a]D: _600 (c=O.OI)
Mass [spectrum 8J: [M+] at m/z 346.10575, C18H1807requires 346.105253 g.mor1
ElMS: m/z 346.10575 (42.5%)
m/z 210 05345 (47.5%)
m/z 183 (7%)
m/z 137 (100%)
Infrared: v ~~I cm-1[spectrum 12J: 3460 (O-H stretching), 2927 (C-H stretching), 2868
(C-H stretching), 1653 (C=O stretching), 1514and 1444 (C=C stretching)
DV: A.~:;12 nm (log E) [spectrum 9J: 356.0 (5.04)
291.0 (5.80)t
207.0 (6.0)
with A1Ch [spectrum 11J: 318.0
with NaOAc [spectrum 10J: 291.0
IH NMR: OH (ppm) CDCh [spectrum IJ: Table 3.1
l3C NMR: Oc (ppm) CDCh [spectrum 2J: Table 3.1
t This peak shifts on addition of AICh in the presence of a hydroxy group at C-5 and on addition ofNaOAc
in the presence of a hydroxy group at C-7
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Physical Description: yellowish-orange gum
Optical rotation: [a]D: +41.7° (c=0.012)
Mass [spectrum 20]: [M+] at 360.12137, CI9H2007 requires 360.120903 g.mor l




Infrared: v ~:;I cm-I [spectrum 24]: 3430 (O-H stretching), 2930 (C-H stretching), 2852
(C-H stretching), 1619 (C=O stretching) and 1521 (C=C stretching)
DV: A~:;12 nm (log s) [spectrum 21]: 339.0 (5.4)
279.0 (5.81)
209.0 (6.1)
with A1Cb [spectrum 23]: 279.0
with NaOAc [spectrum 22]: 279.0
IH NMR: DH (ppm) CDCb [spectrum 13]: Table 3.2
13C NMR: Dc (ppm) CDCb [spectrum 14]: Table 3.2
73
3.5.3 Physical data for Compound III
Name: (22R,23S)-17a.,23-epoxy-3~,22,29-trihydroxy-27-nor-lanost-8-en-24-one (22~­
hydroxy-15-deoxoeucosterol)
Yield: 46 mg from Ledebouria zebrina, 20 mg from Scilla natalensis, 20 mg used for
acetylation
Physical Description: white crystals
Melting point: 233-238°C (Literature value: 235-239 °C)lO
Optical Rotation: [0.]0: _18 0 (c=0.096) (Literature: [0.]0:-36.70 (c=0.22»IO
tMass [spectrum 31J: [~] not seen, [M-H20t at 456 g.mor
l




Infrared: v:: cm'l [spectrum 32J: 3420 (O-H stretching), 2933 (C-H stretching), 2877
(C-H stretching) and 1720 (C=O stretching)
IH NMR: DH (ppm) CD30D [spectrum 25]: Table 3.4
I3C NMR: Dc (ppm) CsDsN [spectrum 26J: Table 3.3
13C NMR: Dc (ppm) CD30D [spectrum 33J: Table 3.4
t High resolution mass spectra were only obtained for novel compounds
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3.5.4 Physical data for Compound IV
Name: 5,7-dihydroxy-3-(4'-hydroxy-3'-methoxybenzyl)-4-chromanone (zebrina C)
Optical Rotation: sample was too dilute
Yield: 13 mg
Physical Description: orange gum
Optical rotation: [a]o: -98.2° (c=0.009)
Mass [spectrum 41]: [~] at m/z 316.09462, C17Hl606requires 316.094688 g.mor1
ElMS: m/z 316.09462 (42%)
m/z 179.03435 (6%)
m/z 137.06054 (100%)
Infrared: v:;' cm-1 [spectrum 45]: 3380 (O-H stretching), 2922 (C-H stretching), 1637
(C=O stretching) and 1522 (C=C stretching)
DV: 1..:;12 nm (log E) [spectrum 42]: 289.0 (5.5)
206.0 (5.8)
with AICh [spectrum 43]: 311.0
with NaOAc [spectrum 44]: 325.0
IH NMR: bH (ppm) CDCh [spectrum 34]: Table 3.6
l3C NMR: bc (ppm) CDCh [spectrum 35]: Table 3.6
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3.5.5 Physical data for Compound V
Name: (23S)-17a,23-epoxy-3~,28,29-trihydroxy-27-norlanost-8-en-24-one
Yield: 50 mg from Ledebouria zebrina, 12 mg from Scilla natalensis
Physical Description: orange-brown gum
Optical Rotation: [a]n: -22.7° (c=0.088) (Literature: [a]n:-27.Oo (c=0.5»12
Mass [spectrum 53]: [M+] at m/z 474.33398, C291460S requires 474.334525 g.mor l





Infrared: v:;' cm- I [spectrum 54]: 3437 (O-H stretching), 2929 (C-H stretching), 2853
(C-H stretching) and 1731 (C=O stretching)
IH NMR: OH (ppm) CDCh [spectrum 46]: Table 3.8
13 s::C NMR: Vc (ppm) CDCh [spectrum 47]: Table 3.8
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Chapter 4: Extractives from Scilla natalensis
4.1 Introduction
Scilla natalensis Planch. (Figure 4.1) belongs to the Hyacinthaceae Family. Plants
belonging to this genus are widely distributed throughout Europe, Africa and Asia.
There are approximately eight species worldwide, of which six are found in southern
Africa.1To the Zulu, S. natalensis is known as inguduza, which means "searching the
body for the cause of the ailment".2
Scilla natalensis is a summer-growing plant, possessing medium to large-sized bulbs
(10-15 cm in diameter), which are mostly exposed above the soil surface.1The bulbs
are covered with brown membranous leaf scales. The leaves are uniformly green and
hairy at times and are about 14 cm long and 4 cm broad at the base.3 The
inflorescence, whose length reaches 35 cm, is erect and rigid and bears deep blue and
occasionally white flowers.4,5 S. natalensis is endemic to the eastern parts of southern
Africa, occurring throughout most of the Eastern Cape, Lesotho, KwaZulu-Natal, the
Free State, Swaziland and in Mpumalanga along the escarpment.6
Scilla natalensis has, for many years, been used by various ethnic groups to treat a
range of ailments. I It is the most popular item in the muthi markets around South
Africa and it is becoming a less common sight in the wild. I It was recently listed as
vulnerable.7 It is used by different tribes for the treatment of different aliments. For
example, the Zulu use decoctions from it as ingredients in infusions taken to facilitate
labour at birth.8 The Sotho eat the cooked bulbs with food as an aperient, include bulb
decoctions in enemas to treat "internal tumours" and rub powdered bulbs into
scarifications over sprains and fractions.9,IQ The Tswana rub the powered bulbs into
the back joints and other parts with the belief that it makes them strong and resilient to
witchcraft.IQ,11 The Swati apply a lotion prepared by boiling the macerated bulbs in
water to boils and veld sores. IQ
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Figure 4.1: Scilla natalensis growing near Blyde Nature Reserve, Mpumalanga Photo: N.Crouch
Previous phytochemical investigations of Scilla natalensis have resulted in the
isolation of two homoisoflavanones (VI and VII).3 The dichloromethane extract only
was investigated in this work. This led to the isolation of ten compounds (Figure 4.2).
Three of the compounds isolated have not been reported previously. Two compounds,
(22R,23S)-17a,23-epoxy-3p,22,29-trihydroxy-27-nor-Ianost-8-en-24-one (Ill) and
(23S)-17a,23-epoxy-3 P,28,29-trihydroxy-27-norlanost-8-en-24-one (V) were
previously isolated from Ledebouria zebrina in this work. Other compounds isolated
were 5,7-dihydroxy-6-methoxy-3-(4'-hydroxybenzyl)-4-chromanone (VI), 5,7-
dihydroxy-6-methoxy-3-(3'-hydroxy-4'-methoxybenzyl)-4-chromanone (VII), (23S)-
17a,23-epoxy-3 p,24~-dihydroxy-27,28,29-trisnor-Ianost-8-ene (VIII), (22R,23S)-
17a,23-epoxy-3P,22,24~-trihydroxy-27,28-bisnor-Ianost-8-ene (IX), (22R,23S)-22-



















Figure 4.2: Compounds isolated from Scilla natalensis
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4.2 Results and Discussion
4.2.1 Structural Elucidation of Compound VI, 5,7-dihydroxy-6-methoxy-3-(4'-
hydroxybenzyl)-4-chromanone (3,9-dihydroeucomnalin)
This compound was previously isolated from the same plant.3 It was isolated as an
orange gum.
OH 0
Figure 4.3: Structure of 3,9-dihydroeucomnalin
Compound VI (Figure 4.3) was found to have a molar mass of 316 g.mor1
corresponding to the molecular formula C17HI606. A double bond equivalence of 10
was deduced. This compound also belongs to the 3 benzyl-4-chromanone type of
homoisoflavanones.
The IH NMR spectrum [spectrum 55] showed the presence of one methoxy group (<5
3.76 ppm). The appearance in the mass spectrum [spectrum 57] of peaks at m/z 209,
183 and 182 corresponding to the A-4 and RDA fragments (Scheme 2.1) gave an
indication that two hydroxy groups and one methoxy group were attached to ring A.
One hydroxy group was assigned to the C-5 position due to a bathochromic shift of 25
nm seen in the DV spectrum [spectrum 60] when AIC!) was added. 12,13 This was
confirmed by the downfield shift of the C-4 carbonyl group (<5 199.6 ppm). The
second hydroxy group was assigned to C-7 due to a bathochromic shift of 40 nm in
the DV spectrum [spectrum 59] when NaOAc was added. 12,13 The methoxy group
was placed at C-6 by comparison against the literature chemical shift data for this
compound.3 The IH NMR spectrum also showed a pair of doublets at <5 7.11 and <5
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6.79 ppm, which indicated that the ring B was a para-disubstituted benzene ring. This
was confirmed by a base peak of m/z 107 in the mass spectrum corresponding to a
hydroxybenzy1 / tropylium ion. The hydroxy group was assigned to C-4'.
A comparison was made of the lH and l3C NMR data of compound VI and data from
literature. Both the l3C and lH NMR data were similar confirming that compound VI
was, in fact, 5,7-dihydroxy-6-methoxy-3-(4'-hydroxybenzyl)-4-chromanone.
Table 4.1: Comparison of I H NMR data of compound VI with
5,7-dihydroxy-6-methoxy-3-(4'-hydroxybenzyl)-4-chromanone3
CD3OD)
IH NMR data for I HNMR
Proton (s) Compound VI Literature data3
(ppm) (ppm)
2H-2
4.22 (dd,7.0,11.4) 4.10 (dd,7.2,11.4)t
4.35 (dd,4.3,l1.4) 4.20 (dd,4.2,11.4)t
H-3 2.75 (m) 2.83 (m)
H-8 5.97 (s) 5.94 (s)
2H-9
2.79 (dd,13.7,10.1) 2.67 (dd,13.5,1O.6)
3.13 (dd,4.4,13.7) 3.13 (dd,4.2,13.5)
H-2'1H-6' 7.11 (d,8.4) 7.09 (d,8.4)
H-3'1H-5' 6.79 (d,8.4) 6.78 (d,8.4)
6-0CH3 3.81 (s) 3.81 (s)
to" In.gma spectra were analysed and showed that these double doublets were inaccurately reported by
prevIous student
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Table 4.2: Comparison of l3C NMR data of compounds VI with
S,7-dihydroxy-6-methoxy-3-(4'-hydroxybenzyl)-4-chromanone3
CD3OD)
Carbon 13C NMR data for l-'CNMR



















#-obscured by solvent peak
*-Comparison with original spectrum in laboratory showed the
compound was not as pure, resulting in the presence ofmore than one
peak in this region and the wrong peaks could have been assigned
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4.2.2 Structural elucidation of Compound VII, 5,7-dihydroxy-6-methoxy-3-(3'-
hydroxy-4'-methoxybenzyl)-4-chromanone
This compound was previously isolated from the same plant.3 It was isolated as a
yellow gum.
OH 0
Figure 4.4: Stucture of Compound VII
Compound VII (Figure 4.4) was found to have a molar mass of 346 g.mor1
corresponding to a molecular formula of C1sHlS07. A double bond equivalence of ten
was deduced. This compound also belongs to the 3-benzyl-4-chromanone-type of
homoisoflavanones.
The IH NMR spectrum [spectrum 62] showed that compound VII had two methoxy
groups (8 3.86, 3.76 ppm). Substitution in ring A was deduced from the mass and lH
NMR spectra. Although the two fragments due to RDA fragmentation could not be
detected in the mass spectrum [spectrum 64] the presence of a low intensity peak at
m/z 209 corresponding to a dihydoxy-methoxychromanone fragment ion was
testimony to the existence of a ring A with two hydroxy and one methoxy group. The
appearance of a singlet integrating to one proton at 8 5.97 ppm (normally H-6/8) in
the lH NMR was also an indication that there was only one unsubsituted position in
ring A. The fact that the chemical shift was upfield of 6.0 ppm provided evidence that
a hydroxy group occurred at C_7. 14,15 This was confirmed by a bathochromic shift of
40 nm with NaOAc. A hydroxy group also occurred at C-5 and this was indicated by
a bathochromic shift of 24 nm with AICh. The methoxy group was placed at position
C-6 by comparison of the chemical shift data.3 Ring B was also found to be
trisubstituted as revealed by the appearance of an aromatic ABX system in the 1H
84
NMR spectrum. A base peak at m/z 137 in the mass spectrum corresponding to a
hydroxy-methoxybenzyl ion indicated that ring B contained one hydroxy and one
methoxy substituent. The methoxy group was assigned to C-4' due to a NOESY
correlation with H-5' and the hydroxy group was placed at C-3'.
A comparison was made of the IH and l3C NMR data of compound VII and that from
the literature. Both the IH and l3C NMR data were similar and it was concluded that
compound VII was, 111 fact, 5,7-dihydroxy-6-methoxy-3-(3-hydroxy-4-
methoxybenzyl)-4-chromanone.
Table 4.3: Comparison of IH NMR data of compound VII with 5,7-dihydroxy-6-
3methoxy-3-(3'-hvdroxv-4'-methoxybenzyl)-4-chromanone (CD30D)
Proton (s) IH NMR data for IHNMR
Compound VII Literature data3
(ppm) (ppm)
2H-2 4.22 (dd,7.1,11.5) 4.10 (dd,7.2,11.4)t
4.38 (dd,4.4,11.3) 4.26 (dd,4.2,11.4)t
H-3 2.87 (m) 2.85 (m)
H-8 5.97 (s) 5.95 (s)
2H-9 2.68 (dd,10.2,13.5) 2.62 (dd,10.2,13.5)
- 3.13 (dd,4.5,13.5) 3.11 (dd,4.5,13.5)
H-2' 6.75 (d,2.1) 6.75 (d;2.1)
H-5' 6.88 (d,8.2) 6.89 (d,8.1)
H-6' 6.70 (dd,2.1, 8.2) 6.70 (dd,2.1, 8.1)
6-0CH3 3.76 (s) 3.81 (s)
4'-OCH3 3.86 (s) 3.86 (s)
to" Ingma spectra were analysed and showed that these double doublets were incorrectly reported
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Table 4.4: Comparison of 13C NMR data of compound VII with 5,7-dihydroxy-6-
3methoxy-3-(3'-hydroxy-4'-methoxybenzyl)-4-chromanone (CD3OD)
13C NMR data for 13CNMR




















#-obscured by solvent peak
*-sample was too weak to decipher these peaks
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4.2.3 Structural elucidation of Compound VIII, (23S)-17a.,23-epoxy-3~,24~­
dihydroxy-27,28,29-trisnor-lanost-8-ene (natalensis A)
This compound was isolated as a white powder and the structure has not been
previously reported.
OH
Figure 4.5: Stucture of natalensis A
The mass spectrum [spectrum 76] showed a molecular ion peak at m/z 416.32916
g.mor1 which corresponded to a molecular formula of C27lI«03. The molecular
formula indicated that two further carbon atoms had been lost from the eucosterol
skeleton. From the molecular formula, a double bond equivalence of six was deduced.
This compound was found to be a derivative of eucosterol type nortriterpenoids
(Figure 4.5).
The IH NMR spectrum [spectrum 69] showed the presence of five methyl groups in
the molecule instead of the six found in eucosterol. The methyl group protons of 3H-
26 and 3H-21 were easily recognized to be present by the presence of a triplet at 8
0.99 ppm for 3H-26 protons and the presence of a doublet at 8 1.04 ppm for the 3H-
21 protons. The remaining methyl group protons all appear as singlets and the one
absent was determined through the HMBC spectrum [spectrum 73]. The HMBC
spectrum shows 3J and 2J correlations from C-13 to two methyl group proton
resonances at 8 1.11 ppm and 8 0.91 ppm. These methyl group protons were assigned
to C-30 and C-18 respectively. The HMBC spectrum also showed a 3J correlation
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from C-9 to a methyl group proton at 8 0.92 ppm. This could only be the methyl
group protons ofC-19. This implied that the methyl group at C-4 was missing. The lH
NMR spectrum did not show the primary hydroxy group protons at C-29 found in
eucosterol. This indicated that at C-4 the C-28 methyl group and the C-29 primary
hydroxy group were both absent.
The l3C NMR spectrum [spectrum 70] did not show the presence of the carbonyl
groups at C-24 and C-15 found in eucosterol. Instead it showed the presence of an
extra secondary hydroxy group methine proton (8 78.9 ppm). The lH NMR
resonance (8 3.35 ppm) showed a COSY [spectrum 74] correlation with the H-23
resonance. This meant that the hydroxy group was either at position C-22 or C-24.
The HMBC spectrum showed a 3J correlation from C-26 to this resonance, indicating
that it was at C-24. The stereochemistry of the hydroxy group on C-24 has not been
detennined due to the small amount of material available. The remaining HMBC,
COSY and NOESY correlations are shown on Table 4.5
The infrared data [spectrum 77] supported the proposed structure. Peaks were
observed at 3396 cm,l (O-H stretching) 2928 cm,l, (aliphatic C-H stretching) and
2864 cm,l (C-H stretching).
A literature for the compound indicated that it was novel and was named natalensis A
(235)-17a,23-epoxy-3p,24~-dihydroxy-27,28,29-trisnor-lanost-8-ene).
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Table 4.5: IH, l3C, HMBC, COSY and NOESY data for (23S)-17a.,23-epoxy-
3f3,24l;-dihvdroxv-27,28,29-trisnor-Ianost-8-ene (CDCh)
IH (ppm) l3C (ppm) HMBC--)oH COSY NOESY
1 1.92(m)(2H) 21.4
2#* H-2a-l.30 (m) 38.3 H-3 H-3
H-2B-1.62 (m) H-3;H-4P
3 3.60 (m) 71.2 H-2 H-4a;H-2
4#* H-4a-1.15 (m) 35.0 H-3
H-4B-1.72 (m) H-2P
5 1.32 (m) 40.4 3H-19 H-6a,B H-6a
6 H-6a-1.96 (m) 41.0 H-5 H-5
H-6B-1.75 (m) H-5




11 H-lla-1.82 (m) 31.6 H-llp;H-12a;p H-12a;H-llp
H-IIB-1.40 (m) H-lla;H-12a,B H-12B;H-lla;3H-19
12 H-12a-2.08 (m) 24.8 3H-18 H-11a;p 3H-30
H-12B-2.20 (m) H-lla,B 3H-21;3H-18;H-llP
13 50.6 3H-18;3H-30
14 48.7 3H-18;3H-30
15 H-15a (d, 1.31) 31.7 3H-30 3H-30
H-15B (d,1.65) 3H-18
16§* 1.15 (m) 35.0
1.72 (m)
17 95.6 3H-21
18 0.91 (s) 19.1 H-20;H-15P;H-12P;
3H-21
19 0.92(S) 17.1 H-11
20 2.18 (m) 44.7 3H-21 3H-21 ;H-22a,p 3H-21;3H-18;
H-22a,B;H-25
21 1.04 17.6 H-22 H-20 H-23;H-12P;
(d,6.8) H-22a;3H-18
22 H-22a-l.51 36.4 3H-21 H-23;H-20 3H-21 ;H-23;H-20
(dd, 6.0, 6.2)
H-22B-l.66** H-23;H-20 H-24;H-20
23 3.82 (m) 80.9 H-20;H- H-22a,p;H-24 3H-21;H-22a
24;H-25
24 3.35 (m) 78.9 3H-26;H-25 H-23;H-25 3H-26'H-25'H-22B, ,
25 1.40(q, 7.3) 25.6 3H-26 3H-26 H-24
26 0.99 (t, 7.3) 9.9 H-24;H-25 H-25 H-24;H-25
30 1.11(s) 26.5 H-15 H-15a;H-12a
#-Interchangeable
§-Interchangeable
*-COSY spectrum too complex in this part of the spectrum to assign these resonances
**- Coupling constant could not be worked out superimposed with other peaks
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4.2.4 Structural elucidation of compound IX, (22R,23S)-17a,23-epoxy-
3J3,22,24~-trihydroxy-27,28-bisnor-Ianost-8-ene (natalensis B)
This compound was isolated a yellowish-white gum and was found to be novel
(Figure 4.5).
Figure 4.6: Structure of natalensis B
The mass spectrum [spectrum 85] showed a molecular ion peak at m/z 446.33844
g.mor1, which corresponds to a molecular formula of C28~604. This indicated that
one carbon atom had been lost from the eucosterol-type structure. From the molecular
formula, a double bond equivalence of six was deduced.
The IH NMR spectrum [spectrum 78] of this compound was very similar to that of
natalensis A. The primary hydroxy group at C-29, and the carbonyl groups at C-24
and C-15 were all missing from this structure. This compound, however, showed the
presence of a 3H-29 methyl proton resonance (8 1.13 ppm) in the IH NMR spectrum
which now appeared as a doublet. The stereochemistry was determined through the
NOESY spectrum [spectrum 84]. The NOESY spectrum showed NOESY
correlations between 3H-29 and 3H-19 and between H-4 and H-5a. This implied that
3H-29 was {3.
90
Using the COSY spectrum [spectrum 83] the 3H-21 methyl group proton resonance
(8 0.99 ppm) was seen to be coupled to H-20 which was, in turn, coupled to an
oxygenated methine resonance (H-22) at 8 4.13 ppm. This showed coupling to H-23
(8 4.01 ppm) and a further oxygenated proton resonance at 8 4.07 ppm which was
assigned to H-24. The H-24 resonance was, in turn, coupled to 2H-25 which was
further coupled to the 3H-26 (8 1.05 ppm) triplet. The corresponding 13C NMR
resonances [spectrum 79] occurred at 816.5, 53.2, 81.2, 83.0, 73.6, 27.9 and 10.9
ppm for 3H-21, H-20, H-22, H-23, H-24, H-25, 3H-26 respectively. The H-22
resonance showed a NOESY correlation with the a hydrogen H-23, indicating that the
hydroxy group at C-22 was ~. The stereochemistry of the hydroxy group on C-24 is
still to be determined, but this requires the re-collection of more plant material and the
isolation of of larger amounts of this compound for the preparation of Mosher esters.
The remaining HMBC, COSY and NOESY correlations are shown on Table 4.6.
The infrared data [spectrum 86] supported the proposed structure. Peaks were
observed at 3393 cm-! (O-H stretching), 2924 cm-! (aliphatic C-H stretching) and
2853 cm-! (C-H stretching).
A literature search for the compound indicated that it was novel and it was named
natalensis B «22R,23S)-17a,23-epoxy-3 ~,22,24~-trihydroxy-27,28-bisnor-Ianost-8-
ene).
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Table 4.6: IH, BC, HMBC, COSY and NOESY data for (22R,23S)-17a,23-epoxy-
3B,22,24e,-trihydroxy-27,28-bisnor-Ianost-8-ene (CsDsN)
lH (ppm) l3C (ppm) HMBC~H COSY NOESY
1 H-la-1.05 (m) 35.5 3H-19
H-IB-1.65 (m) H-2~;H-3 3H-19;3H-29;H-2~
2 H-2a1.72 (m) 32.6
H-2B1.93 (m) H-3 3H-19;H-3
3 3.16 (m) 75.6 3H-29;H-2,a,b; H-2;H-4 H-2~;3H-19;3H-29
H-4
4 1.41 (m) 39.9 3H-29;H-2;H-3, H-3- H-5
5 # 47.5 3H-19;3H-29; H-4
H-4;H-2
6** H-6a-1.93 (m) 21.8
H-6B-2.06 (m) H-7a,~ H-7~
7** H-7a-1.16 (m) 21.2 H-7~




11 H-l1a-2.06 (m) 25.7
H-I1B-1.92 (m) 3H-18
12 1.42 (m) (2H) 25.6 3H-18 3H-18,3H-21
13 50.3 3H-30;H-20
14 50.1 3H-18;H-16
15 H-15a-l.30 (m) 32.2 3H-30;H-16 H-16a,~
H-15B-1.55 (m) H-16a,B 3H-18
16 H-16a-2.68 (m) 41.2 H-20 H-15a,~ 3H-30
H-16B-2.28 (m) H-15a,B H-20
17 95.3 3H-21;H-23;H-
15;H-22,;H-18
18 0.88 (s) 19.6 H-16 H-20;H-15;H-21 ;H-
IIB;H-12
19 0.90 (s) 18.4 3H-29;H-3;H-6
20 2.39 (m) 53.2 3H-21 3H-21; 3H-21;3H-18;H-
H-22 1613
21 0.99 (d,7.1) 16.5 H-22;H-20 H-20 H-22;H-23;H-
20;3H-18;H-12
22* 4.13 81.2 3H-21;H-20 H-23;H-22 H-23;3H-18
23* 4.01 83.0 H-22,H-20; H-22 H-22;H-25;3H-21
H-25;
24* 4.07 73.6 H-25;3H-26; H-25 H-25;H-26
25 1.75 (q, 7.3) 27.9 H-23;3H-26; 3H-26;H-24 H-23;H-24;3H-26
26 1.05 (t,7.3) 10.9 H-25 H-24;H-25
29 1.13(d,6.2) 15.8 H-3;H-4;H-5 H-3;3H-19;H-l B
30 1.33 26.9 H-16a
*-peaks obscured, J values could not be detennmed
**- carbon values interchangeable
#-obscured by 3H-18, 3H-19
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4.2.5 Structural elucidation of Compound X, (22R,23S)-22-acetoxy-17a.,23-
epoxy-3~,29-dihydroxy-27-nor-Ianost-8-en-24-one(22~-acetoxy-15­
deoxoeucosterol)
This was the tenth compound isolated during the course of this work. It was isolated
as white crystals with a melting point of 180°C.
Figure 4.7: Structure of 2213-acetoxy-15-deoxoeucosterol
The mass spectrum [spectrum 93] did not show a molecular ion peak but showed an
[M+-CH3COOH] fragment at m/z of 456. The molecular formula was found to be of
C31Htg06 from the mass spectrum in conjunction with the NMR spectra and a double
bond equivalence of 8 was deduced. The compound isolated also belongs to the class
of compounds known as the eucosterol-type triterpenoids (Figure 4.7).
The IH NMR spectrum [spectrum 87] of this compound was very similar to that of
eucosterol and to that of compound IV. It showed the presence of an extra methyl
group proton resonance, which was an acetoxy methyl group proton resonance (8 1.99
ppm). The HMBC spectrum [spectrum 90] showed a 2J correlation from the carbonyl
carbon of the acetate to this methyl group proton resonance and a 3J correlation to the
methine proton resonance of C-22. The acetate group was therefore placed at C-22.
The H-22 resonance showed a NOESY correlation with H-23a., indicating that the
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acetoxy group at C-22 was ~. The remaining HMBC, NOESY and COSY data are
shown in Table 4.8.
The infrared data [spectrum 94] supported the postulated structure. Peaks were
observed at 3427 cm-I (O-H stretching), 2917 cm-I (aliphatic C-H stretching), 2852
cm-I (aliphatic C-H stretching) and 1734 cm-I (C=O stretching).
Finally a literature search for the compound was undertaken. It was found to be
(22R,23S)-22-acetoxy-17a,23-epoxy-3 ~,22-dihydroxy-27-nor-Ianost-8-en-24-one a
compound previously isolated from Veltheimia bracteata (syn. V. viridifolia) and
Ledebouria cooperi. 16,17 A comparison was made with the NMR data of the
compounds from literature. However one was run in pyridine, the other in deuterated
methanol and compound X in deuterated chloroform. In order to get a better
comparison, compound X, was re-run in deuterated methanol as no deuterated
pyridine was available [spectrum 95], Table 4.7 shows a comparison of 13C NMR
data compound X and literature. 16 The data compared quite favourable. Compound X
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Table 4.7: Comparison of l3C NMR data for compound X with (22R,23S)-
22-acetoxy-17a,23-epoxy-3~,29-dihydroxy-27-nor-Ianost-8-en-24-one16
(CD30
#-obscured by solvent sIgnal
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TABLE 4.8: t H, 13C, HMBC, COSY and NOESY data for (22R,23S)-22-acetoxy-
17a.,23-epoxy-313,29-dih, droxy-27-nor-lanost-8-en-24-one (CDCh)
Carbon IH 13C HMBC~H COSY NOESY
(ppm) (ppm)
1 H-1a.-1.18 (m) 35.2 3H-19;H-2 H-1 H-3
H-ll3-1.72 (m) 3H-19;H-2
2 1.76 (m) (2H) 28.2 H-3;H-1a.,13 H-1a.
3 3.41 (m) 80.7 H-3 H-2 H-1a.
4 42.7 H-30;H-5
5 2.55 (m) 51.1 3H-19;3H-28 H-6
6 H-6a.-1.74 (m) 18.2 H-5 H-7;3H-28
H-613-1.40 (m) 3H-19




11 2.05 (m) (2H) 20.7 H-12a.,13 3H-18
12 H-12a.-2.16 (m) 24.8 3H-18 H-11 3H-30;H-12~





15 H-15a.-1.38 (m) 32.0 3H-30;H-20 H-16a.,~
H-1513-1.64 (m) H-16a.,13 3H-18
16 H-16a.-2.32 (m) 39.9 H-20;H-15 H-15a.,~
H-1613-1.84 (m) H-15a.,13 H-20
17 97.4 3H-18;3H-21 ;H-
22;H-23;CH3COO
18 0.95 (s) 19.2 H-12 H-20;H-21;H-
16a;H-1213;H-11
19 0.99 (s) 19.8 H-5 H-29
20 2.38 (m) 49.1 3H-21 H-20 3H-18;H-
22;3H-21;H-1613
21 1.07 (d,7.1) 15.3 H-20;H-22 3H-21 H-22;H-23;H-
20;3H-18;H-1213
22 5.12 (d,5.1) 82.0 H-20;3H-21; H-23 H-23 H-23;3H-21 ;H-
20
23 4.72 (d,S.l) 84.6 H-20 H-22 H-22;3H-21;H-
25
24 210.0 3H-26;H-25;H-23
25 2.50 (q,7.l) 33.3 3H-26 H-25 H-23;3H-26
26 1.04 (t,7.1) 7.1 H-25 3H-26 H-25;3H-18
28 1.25 (s) 22.2 H-5;H-6 H-3;H-613
29 3.30 (d,11.0) 64.3 3H-28 H-29a 3H-19
4.20 (d,11.2) H-29b
30 1.30 (s 25.8 H-15
CH3COO 1.99 (s 21.0
CH3COO 169.9 CfuCOO;H-22
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Figure 4.8: Structure of scillascillin
This compound (Figure 4.8) was isolated as an amorphous material.
The IH NMR spectrum [spectrum 96] showed the presence of two sets of doublets
for the methylene protons at C-2 and C-9. The proton at C-3 is absent and this is
typical of scillascillinoid-type compounds. The 2H-2 proton resonances occur
downfield at 8 4.41 (d, 11.1 Hz) and 4.46 (d, 11.1 Hz) ppm because of the presence of
an adjacent oxygen atom. The H-9 protons were found to occur at 8 2.92 (d, 13.5 Hz)
and 3.42 (d, 13.5 Hz) ppm. The IH NMR spectrum also showed the presence of an
extra methylene group. The methylene carbon was found to resonate at 8 100.2 ppm
in the 13C NMR [spectrum 97]. It was assigned to the carbon of a methylene dioxy
group.
The presence of a pair of doublets at 8 6.52 and 6.64 (J=<IHz) each integrating to one
proton were indicative of protons para to each other and this implied aI', 3', 4', 6'-
tetra-substituted ring B. The HMBC spectrum [spectrum 99] showed a 3J correlation
from C-3' and C-4' to the proton resonance of the methylene dioxy group (2H-7'). This
group was placed between C-3' and C-4'.
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The substitution pattern in ring A was determined through DV and 1H NMR spectra.
One hydroxy group was assigned to the C-5 position due a bathochromic shift of 27
nm in the DV spectrum [spectrum 104] with AlCb. 12,13 This was confirmed by the
downfield shift of the carbonyl group (8 196.0 ppm) that becomes deshielded due to
the chelating effects with the hydroxy group.I2,13 The second hydroxy group was
placed at C-7 due to a bathochromic shift of21 nm [spectrum 103] when NaOAc was
added. 12,13 This assignment was confirmed by a coupling constant of 2.2 Hz, which
was due to meta coupling between H-6 and H-8.
A literature search for the compound resulted in it being found to be scillascillin itself,
previously isolated from Scilla scilloides and Muscari neglectum. 18,19 The IH (Table
4.9) and 13C (Table 4.10) NMR data were compared to literature. 18 There were certain
discrepancies and this was attributed to the fact that a mixture of solvents were used
since scillascillin was only partial soluble in chloroform so methanol was also added,
while the literature sample was run only in CD30D.
cyclobuta[f] [1,3]benzodioxol]-4-one (CD3ODy
IH NMR data for IHNMR
Proton Compound XI Literature datal8
(ppm) (ppm)
2-H 4Al (d, 11. 1 Hz) 4.501
4A6(d, 11.1 Hz) 4.53 t
9-H 2.92 (d, 13.5 Hz) 2.97






Table 4.9: Comparison of IH NMR data of compound XI (CDCh +
CD30D) with 5,7-dihydroxyspiro[2H-l-benzopyran-3-(4H),5' (6'H)-
18
t Coupling constants not given in literature
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cyclobutarfl [1,3]benzodioxol]-4-one (CD3OD)
Carbon I H NMR data for IHNMR























4.2.7 Structural Elucidation of Compound XII, (23S)-17a.,23-epoxy-3~,29­
dihydroxy-27-nor-Ianost-8-en-24-one (15-deoxoeucosterol)
This compound was isolated as a yellow gum. It was also found to be a derivative of
eucosterol-type nortriterpenoids.
o
Figure 4.9: Structure of 15-deoxoeucosterol
This compound (Figure 4.9) showed the same number of methyl group protons as
eucosterol (six methyl groups). The C-O region of the 13C NMR spectrum [spectrum
106] showed the methylene carbons C-29 (0 64.2 ppm) and methine carbon at C-3 (0
80.7 ppm) and the fully substituted C-17 and C-21. All of this was similar to
eucosterol. However, the 13C NMR spectrum only showed the presence of one
carbonyl group. This carbonyl group was assigned to C-24. The HMBC [spectrum
108] showed a 3J correlation from the carbonyl group to the triplet methyl resonance
protons of3H-26. This confirmed that the carbonyl group was at C-24.
Finally a literature search of the compound was undertaken. The compound was
found to be (23S)-17a.,23-epoxy-3~,29-dihydroxy-27 -nor-Ianost-8-en-24-one a
compound previously isolated from Scilla scilloides.20 In order to confirm the
structure, the carbon data was compared with that of literature. The reference
compound, however, was run in pyridine while compound XII was run in deuterated
chloroform. However an attempt to get a 13C NMR spectrum of compound XII in
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pyridine failed as the compound had decomposed. Table 4.11 shows the carbon data
in different solvents and Table 4.12 shows the HMBC, COSY and NOESY data.
Table 4.11: Comparison of l3C data of Compound XII (CDCh) with (23S)-
2017a.,23-epoxv-313,29-dihvdroxv-27-nor-Ianost-8-en-24-one (CsDsN)
13CNMR data for l3CNMR

































Table 4.12: IH, l3C, HMBC, COSY and NOESY data for (23S)-17a,23-epoxy-
3B,29-dihvdroxv-27-nor-lanost-8-en-24-one (CDCh)
IH (ppm) l3C (ppm) HMBC~Ht COSY NOESY
1 1.17 (m)-(2H) 35.3 3H-19 H-2 3H-19
2 1.75 (m)(2H) 28.2 H-3;H-29 H-19;H-29
3 3.45(m) 80.7 H-1 H-3 3H-28
4 42.8 3H-28
5 l.l5 5l.l 3H-19;3H-28 H-6a,B
6 H-6a-1.73 (m) 18.2 H-5;H-7 H-28
H-6B-1.36 (m) H-5;H-7 H-7;3H-19




11 1.99 (m) (2H) 22.7 H-12 3H-19;H-12
12 1.98 (m) (2H) 24.8 3H-18 H-11 3H-18;H-l1
13 48.6 3H-18;3H-30
14 50.5 3H-18;3H-30
15 H-15a-1.34 (m) 31.7 3H-18;3H-30 H-16a,~;H-15~ 3H-30
H-15B-1.60 (m) H-16a,B;H-15a 3H-18
16 H-16a-1.98 (m) 39.6 3H-18 H-15a,~;
H-16B-1.62 (m) H-15a.,B 3H-18;H-20
17 97.0 3H-18;3H-21
18 0.87 (s) 19.1 H-12 H-20;H-16~;H-
15~;H-12~; 3H-
21
19 0.92 (s) 19.9 H-5 H-29b;H-ll;H-
613
20 2.15 43.5 3H-21 3H-21 ;H-22a.,~ H-16~;3H-
21·3H-18·H-22S·, , ,
21* 1.04 17.1 H-22 H-20 H-23;H-20;H-
220.; 3H-18
22* H-22a-1.81 (m) 36.7 3H-21 H-23 H-23;H-22a.;3H-
H-22~-1.92 (m) H-23 21
H-20




25 2.54 (q,7.3) 32.2 3H-26 3H-26 3H-26
26* 1.06 7.4 H-25 H-25 H-25
28 1.21 25.8 H-3;H-6a.
29 H-29a-3.32 (d,10.8) 64.4 H-28 H-29b H-29b
H-29b-4,22 (d,11.2)
H-29a 3H-19;H-29a
30 1.23 22.2 H-15 H-15a
*- coupling constant could not be detenmned because ofpoor reolution and it being superimposed
t The HMBC correlations have been tentatively assigned because no expansion could be obtained-
problems with NMR spectrometer
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Figure 4.10: Structure of natalensis C
Natalensis C was isolated as white crystals with a melting point between 88-90°C. It
was found to be a derivative of eucosterol type nortriterpenoids. The mass spectrum
[spectrum 111] showed a molecular ion peak at m/z 472.31953 g.mor1, which
corresponded to a molecular formula of C29H440S.
The l3C NMR spectrum [spectrum 112] showed the presence of two carbonyl groups.
The carbonyl carbon resonance at 8 210.4 ppm had a 3J correlation, in the HMBC
spectrum [spectrum 114], with the methyl group triplet resonance of 3H-26
indicating it was at C-24. The second carbonyl carbon resonance at 8 214.5 ppm had
3J correlations with the methyl group proton resonance of 3H-28 and with the
oxygenated methylene proton resonance of 2H-29, indicating the second carbonyl
resonance was at C-3. The C-O region of the l3C NMR spectrum showed the presence
of an extra methine proton (8 79.3 ppm). The HMBC spectrum showed 3J correlations
from C-17 and C-21 to the oxygenated methine proton resonance indicating the
resonance was at C-22. This assignment was confirmed through the COSY [spectrum
115] correlation with the H-23 resonance, indicating it to be at C-22. A NOESY
[spectrum 116] correlation occurred between the resonance of H-23a. and the
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oxygenated methine proton resonance, indicating the proton to be a and the hydroxy
group to be ~.
A literature search for the compound was done and it was found to be novel. It was
named natalensis C. Table 4.13 shows the HMBC, COSY and NOESY data.
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Table 4013: IH, l3C, HMBC, COSY and NOESY data (22R,23S)-17a,23-epoxy-
22 29 dOh d 27 I t 8 3 24 dO e, - I .,. roxy- -nor- anos - -en- , - Ion
IH lJC HMBC~H COSY NOESY
(ppm) (ppm)
1 1.93 (m) (2H) 20.7 3H-19




6 H-6a-1.63 (m) 19.1 3H-28
H-6B-1.53 (m) 3H-19




11 H-11a-2.78 (m) 35.2 H-12a,~
H-11B-2.21 (m) 3H-19
12 H-12a-1.36 (m) 24.8 3H-18 H-lla
H-12B-2.30 (m) H-lla 3H-18;3H-21
13 49.6 3H-18
14 49.3 3H-30
15 H-15a-1.34 (m) 32.0 3H-30 H-15~
H-15B-1.59 (m) H-15a 3H-18;




18 0.84 (s) 18.9 H-15~;3H-
21;H-20
19 1.13 (s) 19.2 H-6~'H-29'H-, ,
lIB
20 2.35 (m) 51.6 3H-21 3H-20 3H-21;H-
22;3H-18
21* 0.94 15.6 H-22 H-20 3H-21;H-
22;3H-18
22 4.42 79.3 3H-21 ;H-20;H- H-23 H-23,3H-21
23
23 4.74 (d) 87.2 H-20 H-22 H-22
24 210.4 3H-26
25 2.51 (d,7.3) 33.0 3H-26 H-26 3H-26
2.61 (d,7.5)
26* 0.96 7.1 H-25 H-25 H-25
28 1.27 19.9 H-29 3H-19;H-29;H-
6a




*- peaks obscured, J could not be detennined
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4.2.9 Compounds re-isolated from Scilla natalensis
Figure 4.11: Structure of Compound III
Compound III which was isolated from Ledebouria zebrina was re-isolated from
Scilla natalensis.
Figure 4.12: Structure of Compound V




Dr Neil Crouch of the National Botanical Institute collected the plant material from a
swamp in the Blyde Nature Reserve and a voucher specimen was retained at the Natal
Herbarium (N. Crouch 855 NH). The part of the plant investigated was the bulbs. The
bulbs (3.08 kg) were chopped into small pieces, air dried for approximately 48 hours
and then extracted successively with dichloromethane (mass of extract 10.65 g) and
methanol (mass of extract 150.6 g) by agitation on a Labcon mechanical shaker at 140
rpm. Extraction with each solvent was carried out for approximately 72 hours. The
extracts obtained were then filtered and the solvent was removed using a BUCHI
rotavapor. The dichloromethane extract has only been worked on to date. General
chromatographic techniques were employed (Section 3.4) and this led to the isolation
of ten compounds: compounds, (22R,23S)-17a,23-epoxy-3 ~,22,29-trihydroxy-27-nor-
lanost-8-en-24-one (Ill) (20 mg), (23S)-17a,23-epoxy-3~,28,29-trihydroxy-27­
norlanost-8-en-24-one (V) (12 mg), 5,7-dihydroxy-6-methoxy-3-(4-hydroxybenzyl)-
4-chromanone (VI) (12 mg), 5,7-dihydroxy-6-methoxy-3-(3-hydroxy-4-
methoxybenzyl)-4-chromanone (VII) (10 mg), (23S)-17a,23-epoxy-3~,24;­
dihydroxy-27,28,29-trisnor-lanost-8-ene (VIII) (20 mg), (22R,23S)-17a,23-epoxy-
3~,22,24~-trihydroxy-27,28-bisnor-lanost-8-ene (IX) (30 mg), (22R,23S)-22-acetoxy-
17a,23-epoxy-3~,22,29-trihydroxy-27-nor-lanost-8-en-24-one(X) (15 mg), with 5,7-
dihydroxyspiro[2H-1-benzopyran-3-(4H),5'(6'H)-cyclobuta[f] [1 ,3]benzodioxol]-4-one




4.3.1 Physical data for Compound VI
Name: 5,7 dihydroxy-6-methoxy-3-(4'-hydroxybenzyl)-4-chromanone
Yield: 12 mg
Physical Description: orange gum
Optical rotation: sample was too dilute







Infrared: v ~I cm-1 [spectrum 61]: 3375 (O-H- stretching), 2924 (C-H stretching),
2855 (C-H stretching), 1634 (C=O stretching), 1506 & 1450 (C=C stretching)
DV: f...~::12 nm (log s) [spectrum 58]: 291.0 (5.6)
214.0 (5.8)
with AIC!) [spectrum 60]: 316.0
with NaOAc [spectrum 59J: 331.0
lHNMR: DH(Ppm) CD30D [spectrum 55]: Table 4.1
l3C NMR: Dc (ppm) CD30D [spectrum 56]: Table 4.2
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4.3.2 Physical data of Compound VII
Name: 5,7-dihydroxy-6-methoxy-3-(3'-hydroxy-4'-methoxybenzyl)-4-chromanone
Yield: 10 mg
Physical Description: yellow gum
Optical rotation: sample was too dilute




Infrared: v ~:;I cm-1 [spectrum 68]: 2926 (C-H stretching), 2856 (C-H stretching),
1733 (C=O stretching) and 1474 (C=C stretching)
DV: A.~:;12 nm (log E) [spectrum 65]: 291.0 (5.6)
205.0(5.8)
with AICh [spectrum 66]: 315.0
with NaOAc [spectrum 67]: 331.0
IH NMR: OH (ppm) CD30D [spectrum 62]: Table 4.3
13C NMR: DC (ppm) CD30D [spectrum 63]: Table 4.4
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4.3.3 Physical data for Compound VIII
Name: (23S)-17a.,23-epoxy-3~,24~-dihydroxy-27 ,28,29-trisnor-Ianost-8-ene
(natalensis A)
Physical Description: yellow gum
Yield: 20 mg
Optical Rotation: [a.]D: +20.4° (c=0.054 g/lOOml)
Mass [spectrum 76]: [M+] at m/z 416.32916, C27Ht403 requires 416.329046 g.mor1






Infrared: v ~:;l cm-1[spectrum 77]: 3396 (O-H stretching), 2928 (C-H stretching) and
2864 (C-H stretching)
IH NMR: bH (ppm) CDCh [spectrum 69]: Table 4.5
13C NMR: bc (ppm) CDCh [spectrum 70]: Table 4.5
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4.3.4 Physical data for Compound IX
Name: (22R,23S)-17o., 23-epoxy-3~, 22,24~-trihydroxy-27,28-bisnor-Ianost-8-ene
(natalenis B)
Physical Description: yellowish-white gum
Yield: 30 mg
Optical Rotation: [o.]D: +8.1° (c=0.08g/100 ml)





Infrared: v::::;t cm-1 [spectrum 86]: 3393 (O-H stretching), 2924 (C-H stretching) and
2853 (C-H stretching)
lH NMR: OH (ppm) CsDsN [spectrum 78]: Table 4.6
BC NMR: Oc (ppm) CsDsN [spectrum 79]: Table 4.6
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4.3.5 Physical data for Compound X
Name: (22R,23S)-22-acetoxy-17a.,23-epoxy-3P,29-dihydroxy-27-nor-lanost-8-en-
24-one (22p-acetoxy-15-deoxoeucosterol)
Physical Description: white crystalline solid
Yield: 15 mg
Melting Point: 180°C (Literature: 176°C)17
Optical Rotation: [a]D: _150 (c=O.09) (Literature: [a]D-17.0o)17






Infrared: v:: cm-1 [spectrum 94]: 3427 (O-H stretching), 2917 (C-H stretching)
2852 (C-H stretching) and 1734 (C=O stretching)
IH NMR: bH(Ppm) CDCh [spectrum 87]: Table 4.7
l3C NMR: be (ppm) CD30D [spectrum 88]: Table 4.8
l3C NMR: be (ppm) CDCh [spectrum 95]: Table 4.7
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Physical Description: orange gum
Optical rotation: Vial brokewith sample in it. The amount recovered was too little to
get optical rotation
Mass: [M+]: Vial broke with sample in it. The amount recovered was too little
too get mass spectrum
Infrared: v~I : Vial broke with sample in it. The amount recovered was too little to
get an IR spectrum
DV: A.~:;12 urn (log E) [spectrum102]: 289.0 (5.5)
206.0 (5.8)
with AICh [spectrum 104]: 311.0
with NaOAc [spectrum103]: 328.0
IH NMR: OH (ppm) CD30D+ CDCh [spectrum 96]: Table 4.9
BC NMR: Oc (ppm) CD30D+ CDCh [spectrum 97]: Table 4.10
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Physical Description: yellow gum
Optical Rotation: Sample decomposed
Mass: [~] Sample decomposed
Infrared: Sample decomposed
IH NMR: OH (ppm) CDCh [spectrum 105]: Table 4.12
BC NMR: Oc (ppm) CDCh [spectrum 106]: Table 4.11, 4.12
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4.3.8 Physical data for Compound XIII
Name: (22R,23S)-17a,23-epoxy-22,29-dihydroxy-27-nor-Ianost-8-en-3,24-dione
(natalensis C)
Physical Description: white crystals
Melting Point: 88-91 QC
Yield: 30 mg
Optical Rotation: Waiting for sample to return from HRMS analysis






Infrared: v:: cm-1 [spectrum 118]: 3439 (O-H stretching), 2949 (C-H stretching)
and 1701 (C=O stretching)
IH NMR: OH (ppm) CD30D [spectrum 111]: Table 4.13
13C NMR: Oc (ppm) CD30D [spectrum 112]: Table 4.12
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The findings contained in this work have proven to be quite interesting. The investigation
of members of the Hyacinthaceae family has provided two types of compounds,
homoisoflavanones and eucosterol type nortriterpenoids. The isolation of
homoisoflavanones was not surprising given the well-documented occurrence of these
compounds in this family. However, the different eucosterol type compounds isolated
were quite interesting in that previously only a small number (ten) of these eucosterol
type nortritepenoids have been reported to occur in the Hyacinthaceae and of those
reported seven contain a pentasaccharide attached to C-3. In this study seven eucosterol
type compounds were isolated of which three were novel and two were reported to occur
for the first time in the Hyacinthaceae.
Ledebouria zebrina yielded three homoisoflavanones of the 3-benzyl-4-chromanone type
and two eucosterol type nortriterpenoids. All three of the homoisoflavanones were novel,
while one of the eucosterol type compounds was reported to occur in the Hyacinthaceae
for the first time. Scilla natalensis yielded ten compounds of which two
homoisoflavanones were of the 3-benzyl-4-chromanone type and one was a scillascillin-
type. Seven eucosterol type nortriterpenoids were isolated of which three were novel and
one was reported to occur in the Hyacinthaceae. The structures of the various compounds
isolated are shown in Scheme 5.1.
The initial antifungal activity of the eucosterol type nortriterpenoid is quite interesting.
No previous biological activity for these types of compounds has been reported. Further
tests of these eucosterol type compounds are to be carried out in the future by
collaborating laboratories
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Future work will be to investigate the methanol extract of Scilla natalensis.
Finally the field of natural product research is proving to be a dynamic one. There is a
constant need to find new drugs for the diseases that plague man. Southern Africa has
well over 25 000 species of higher plants and the Cape Floral Kingdom has nearly 9 000
species making it the most diverse temperate flora on earth. With South Africa's
remarkable biodiversity and cultural diversity, it is not surprising to find that
approximately 4 000 species of plants are used as medicines, and of these, some 350
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Spectrum 11: UV spectrum of Compound (1) with AICh
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Spectrum 23: UV spectrum of Compound (lI) with AICI)
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Spectrum 32: IR spectrum of Compound (Ill)
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Spectrum 56: 13C NMR spectrum of Compound (VI) (CD30D)
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Spectrum 69: lH NMR spectrum of Compound (VIII) (CDCh)
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"The mass spectrum shows a mixture
of two compounds with molar masses
of 430.30692 and 416.32916 g.mor1"
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Spectrum 118: IR spectrum of Compound (XIII)
